Epitope.Sequence,MHC.Allele.Name,Assay.Type.Category,Assay.Result,Method,Measurement,Neon.Percent.Rank
AAAYFVGYLK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
AAAYFVGYLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
AAAYFVGYLK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
AAAYFVGYLK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
AAYFVGYLK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
AAYFVGYLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
AAYFVGYLK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
AAYFVGYLK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ACADGTRHTY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
ACADGTRHTY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
ACADGTRHTY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
ACADGTRHTY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
ACADGTRHTY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
ACADGTRHTY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
ADAGFMKQY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
ADAGFMKQY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
ADAGFMKQY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
ADAGFMKQY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
ADAGFMKQY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
ADAGFMKQY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
ADYSVLYNST,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),60
ADYSVLYNST,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
ADYSVLYNST,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
ADYSVLYNST,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
ADYSVLYNST,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
ADYSVLYNST,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
AEAAVKPLL,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
AEAAVKPLL,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
AEAAVKPLL,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
AEAAVKPLL,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
AEAAVKPLL,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
AEAAVKPLL,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
AEAAVKPLLA,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
AEAAVKPLLA,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
AEAAVKPLLA,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
AEAAVKPLLA,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
AEAAVKPLLA,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
AEAAVKPLLA,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
AEGSRGGSQA,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
AEGSRGGSQA,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
AEGSRGGSQA,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
AEGSRGGSQA,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
AEGSRGGSQA,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
AEGSRGGSQA,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
AEILIIIMRT,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
AEILIIIMRT,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
AEILIIIMRT,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
AEILIIIMRT,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
AEILIIIMRT,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
AEILIIIMRT,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
AEIRASANLA,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
AEIRASANLA,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
AEIRASANLA,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
AEIRASANLA,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
AEIRASANLA,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
AEIRASANLA,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
AEVQIDRLI,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
AEVQIDRLI,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
AEVQIDRLI,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
AEVQIDRLI,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
AEVQIDRLI,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
AEVQIDRLI,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
AEVQIDRLIT,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
AEVQIDRLIT,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
AEVQIDRLIT,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
AEVQIDRLIT,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
AEVQIDRLIT,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AEVQIDRLIT,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
AEVVKLPSRY,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
AEVVKLPSRY,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
AEVVKLPSRY,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
AEVVKLPSRY,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
AEVVKLPSRY,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
AEVVKLPSRY,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
AFLLFLVLI,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
AFLLFLVLI,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AFLLFLVLI,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AFLLFLVLI,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),42
AFLLFLVLI,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
AFLLFLVLI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
AFNCTFEYI,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
AFNCTFEYI,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
AFNCTFEYI,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
AFNCTFEYI,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
AFNCTFEYI,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
AFNCTFEYI,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
AFQHQNSKK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
AFQHQNSKK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
AFQHQNSKK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
AFQHQNSKK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
AFRDVLVVL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
AFRDVLVVL,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
AFRDVLVVL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AFRDVLVVL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
AFRDVLVVL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
AFRDVLVVL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
AFSLDVSEK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
AFSLDVSEK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
AFSLDVSEK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
AFSLDVSEK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
AIAACAMLLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
AIAACAMLLV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
AIAACAMLLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
AIILASFSA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
AIILASFSA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6.5
AIILASFSA,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),19
AIKCVDIVK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,37
AIKCVDIVK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
AIKCVDIVK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1
AIKCVDIVK,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,1
AIKCVDIVK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.6
AIKCVDIVK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.6
AIKCVDIVK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
AIKCVDIVK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
AIKCVDIVK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
AIKCVDIVK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
AIMTRCLAV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
AIMTRCLAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
AIMTRCLAV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),15
AITTSNCAK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
AITTSNCAK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,27
AITTSNCAK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,1
AITTSNCAK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1
AITTSNCAK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
AITTSNCAK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.4
AITTSNCAK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
AITTSNCAK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
AITTSNCAK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
AITTSNCAK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
AIYVFCISL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
AIYVFCISL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
AIYVFCISL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),4.5
ALALLLLDR,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,4
ALALLLLDR,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,10
ALALLLLDR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ALALLLLDR,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
ALALLLLDR,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
ALALLLLDR,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
ALALLLLDR,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,23
ALALLLLDR,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,31
ALALLLLDRL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.3
ALALLLLDRL,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,1.3
ALALLLLDRL,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,3.5
ALALLLLDRL,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,4.5
ALALLLLDRL,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,55
ALALLLLDRLN,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,28
ALALLLLDRLN,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,65
ALALLLLDRLN,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,65
ALALLLLDRLN,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,90
ALCTLLHLHR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
ALCTLLHLHR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
ALCTLLHLHR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
ALCTLLHLHR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
ALDGVLSTFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
ALDGVLSTFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
ALDGVLSTFV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),9
ALIARCWYL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
ALIARCWYL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
ALIARCWYL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.175
ALIARCWYL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.175
ALIARCWYL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9
ALIARCWYL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
ALIRATSTR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
ALIRATSTR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
ALIRATSTR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
ALIRATSTR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
ALIYFLQCI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
ALIYFLQCI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
ALIYFLQCI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
ALIYFLQCI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
ALIYFLQCI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
ALIYFLQCI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
ALLADKFPV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
ALLADKFPV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
ALLADKFPV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),14
ALLFLMSFT,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
ALLFLMSFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6.5
ALLFLMSFT,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),46
ALLFLMSFTI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
ALLFLMSFTI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
ALLFLMSFTI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),28
ALLLLDRLN,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,5
ALLLLDRLN,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,12
ALLLLDRLN,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,24
ALLLLDRLN,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,55
ALLLLDRLNQ,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,7.5
ALLLLDRLNQ,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,18
ALLLLDRLNQ,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,38
ALLLLDRLNQ,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,70
ALNTLVKQL,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.3
ALNTLVKQL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.3
ALNTLVKQL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.3
ALNTLVKQL,HLA-A02:01,T Cell,Positive,51 chromium,cytotoxicity,0.3
ALNTPKDHI,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,2.5
ALNTPKDHI,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,2.5
ALNTPKDHI,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,2.5
ALNTPKDHI,HLA-A02:01,T Cell,Positive-Low,ELISPOT,IFNg release,2.5
ALQEAYYRA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
ALQEAYYRA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
ALQEAYYRA,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),33
ALRANSAVK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
ALRANSAVK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
ALRANSAVK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.5
ALRANSAVK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
ALRANSAVK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
ALRANSAVK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
ALRANSAVK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.9
ALRANSAVK,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
ALRANSAVK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
ALRANSAVK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
ALRANSAVK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5
ALRANSAVK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
ALRANSAVK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
ALRANSAVK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
ALRANSAVK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
ALRANSAVK,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
ALRANSAVK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,40
ALRANSAVK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,40
ALSGVFCGV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
ALSGVFCGV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
ALSGVFCGV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1.5
ALVCYIVMPV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
ALVCYIVMPV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
ALVCYIVMPV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),15
ALVFLILCFT,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
ALVFLILCFT,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
ALVFLILCFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9
ALVFLILCFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
ALVFLILCFT,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),28
ALVFLILCFT,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
ALVLLILMTA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2
ALVLLILMTA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
ALVLLILMTA,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),31
ALVSGTATA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ALVSGTATA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
ALVSGTATA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
ALVSGTATA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
ALVSGTATA,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),11
ALVSGTATA,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
ALWEIQQVV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
ALWEIQQVV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
ALWEIQQVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.02
ALWEIQQVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
ALWEIQQVV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.02
ALWEIQQVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
ALWEIQQVV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
ALWEIQQVV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
ALWEIQQVV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
ALWEIQQVV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
ALWEIQQVV,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
ALWEIQQVV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
ALWEIQQVV,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
ALWEIQQVV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
ALWEIQQVV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
ALWEIQQVV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
ALWEIQQVV,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
ALWEIQQVV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.2
ALWEIQQVV,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.2
ALWEIQQVV,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
ALWEIQQVV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
ALWEIQQVV,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
ALYKGFQFI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ALYKGFQFI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
ALYKGFQFI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
ALYKGFQFI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
ALYKGFQFI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
ALYKGFQFI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
AMQTMLFTM,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
AMQTMLFTM,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
AMQTMLFTM,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),47
AMWLLLLSI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
AMWLLLLSI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
AMWLLLLSI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
AMWLLLLSI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
AMWLLLLSI,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
AMWLLLLSI,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),21
APAICHEGKA,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
APAICHEGKA,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),34
APAICHEGKA,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
APAICHEGKA,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
APAICHEGKA,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
APATVCGPKL,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
APATVCGPKL,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
APATVCGPKL,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
APATVCGPKL,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
APATVCGPKL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
APHGVVFLHV,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
APHGVVFLHV,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
APHGVVFLHV,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
APHGVVFLHV,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
APHGVVFLHV,HLA-B54:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
APHHVVAVI,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
APHHVVAVI,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
APHHVVAVI,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
APHHVVAVI,HLA-B53:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
APHHVVAVI,HLA-B54:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
APHLLLIVI,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
APHLLLIVI,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
APHLLLIVI,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
APHLLLIVI,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
APHLLLIVI,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
APSASAFFGM,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
APSASAFFGM,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
APSASAFFGM,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
APSASAFFGM,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
APSASAFFGM,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
APYMVGDVI,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.25
APYMVGDVI,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
APYMVGDVI,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
APYMVGDVI,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,3
APYMVGDVI,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
APYMVGDVI,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
APYMVGDVI,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
APYMVGDVI,HLA-C05:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),29
AQALNTLVK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AQALNTLVK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
AQALNTLVK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
AQALNTLVK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
AQFAPSASA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
AQFAPSASA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
AQFAPSASA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
AQFAPSASA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
AQFAPSASA,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
AQFAPSASA,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),14
AQFLYLYAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
AQFLYLYAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
AQFLYLYAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
AQFLYLYAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
AQFLYLYAL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
AQFLYLYAL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),7
AQMGTLLIA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
AQMGTLLIA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
AQMGTLLIA,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),47
AQPLPQRQK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
AQPLPQRQK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
AQPLPQRQK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
AQPLPQRQK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
AQPLPQRQKK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
AQPLPQRQKK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
AQPLPQRQKK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
AQPLPQRQKK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
ASAFFGMSR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
ASAFFGMSR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
ASAFFGMSR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
ASAFFGMSR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
ASANLAATK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
ASANLAATK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
ASANLAATK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
ASANLAATK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
ASLGPLRETY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
ASLGPLRETY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
ASLGPLRETY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
ASLGPLRETY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
ASLGPLRETY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
ASLGPLRETY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
ASLPTTIAK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
ASLPTTIAK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
ASLPTTIAK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.07
ASLPTTIAK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.07
ASLPTTIAK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
ASLPTTIAK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
ASLPTTIAK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
ASLPTTIAK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
ASLPTTIAK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
ASLPTTIAK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
ASLPTTIAK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
ASLPTTIAK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
ASLPTTIAK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
ASLPTTIAK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
ASLPYGANK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
ASLPYGANK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
ASLPYGANK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
ASLPYGANK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
ASSEVAVLY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
ASSEVAVLY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
ASSEVAVLY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
ASSEVAVLY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
ASSEVAVLY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
ASSEVAVLY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
ATAGWTFGA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
ATAGWTFGA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
ATAGWTFGA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
ATAGWTFGA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
ATAGWTFGA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
ATAGWTFGA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
ATEGALNTPK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
ATEGALNTPK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ATEGALNTPK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
ATEGALNTPK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
ATFSVPMEK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
ATFSVPMEK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
ATFSVPMEK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
ATFSVPMEK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
ATFSVPMEK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
ATFSVPMEK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
ATFSVPMEK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
ATFSVPMEK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
ATFSVPMEK,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
ATFSVPMEK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
ATFSVPMEK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
ATFSVPMEK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.1
ATFSVPMEK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
ATFSVPMEK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
ATFSVPMEK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,36
ATFSVPMEK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
ATFSVPMEK,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
ATFSVPMEK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
ATFSVPMEK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
ATKIIALNK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
ATKIIALNK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
ATKIIALNK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
ATKIIALNK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
ATNNVFRLK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.09
ATNNVFRLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
ATSRTLSYY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
ATSRTLSYY,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
ATSRTLSYY,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
ATSRTLSYY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
ATSRTLSYY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
ATSRTLSYY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
ATSRTLSYY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
ATSRTLSYY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
ATSRTLSYY,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
ATSRTLSYY,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
ATSRTLSYYK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
ATSRTLSYYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ATSRTLSYYK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
ATSRTLSYYK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
ATSTGNYNY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
ATSTGNYNY,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
ATSTGNYNY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
ATSTGNYNY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
ATSTGNYNY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
ATSTGNYNY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
ATSTGNYNY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
ATSTGNYNY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
ATSTGNYNY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
ATSTGNYNY,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
ATSTGNYNYK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
ATSTGNYNYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
ATSTGNYNYK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
ATSTGNYNYK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
ATSTRHPSK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
ATSTRHPSK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
ATSTRHPSK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
ATSTRHPSK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
ATVVIGTSK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.4
ATVVIGTSK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
ATVVIGTSK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ATVVIGTSK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
ATVVIGTSK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.07
ATVVIGTSK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.07
ATVVIGTSK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
ATVVIGTSK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
AVAVHDFFK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.2
AVAVHDFFK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.2
AVAVHDFFK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
AVAVHDFFK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.06
AVAVHDFFK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.06
AVAVHDFFK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
AVAVHDFFK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
AVAVHDFFK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
AVDPAKAYK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.6
AVDPAKAYK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
AVDPAKAYK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AVDPAKAYK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
AVDPAKAYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.3
AVDPAKAYK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.3
AVDPAKAYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
AVDPAKAYK,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
AVDPAKAYK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
AVDPAKAYK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
AVDPAKAYK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3
AVDPAKAYK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
AVDPAKAYK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
AVDPAKAYK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,39
AVDPAKAYK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
AVDPAKAYK,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
AVDPAKAYK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
AVDPAKAYK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
AVIIRGHLR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
AVIIRGHLR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
AVIIRGHLR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
AVIIRGHLR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AVLQSGFRK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.05
AVLQSGFRK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
AYFPREGVF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
AYFPREGVF,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
AYFPREGVF,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
AYFPREGVF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
AYFPREGVF,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
AYFPREGVF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
AYSNNTIAI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
AYSNNTIAI,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
AYSNNTIAI,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.175
AYSNNTIAI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
AYSNNTIAI,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
AYSNNTIAI,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
AYSNRNRFL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
AYSNRNRFL,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
AYSNRNRFL,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
AYSNRNRFL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),37
AYSNRNRFL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
AYSNRNRFL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
CADGTRHTY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.15
CADGTRHTY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.15
CADGTRHTY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.15
CADGTRHTY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
CADGTRHTY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
CADGTRHTY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
CADGTRHTY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),31
CADGTRHTY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
CADGTRHTY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
CADGTRHTY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,27
CADGTRHTY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
CADGTRHTY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
CADGTRHTY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
CADGTRHTY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
CADGTRHTY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
CADGTRHTY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
CADGTRHTY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
CADGTRHTY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
CADGTRHTY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2
CADGTRHTY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2
CADGTRHTY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
CADGTRHTY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
CADGTRHTY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.25
CADGTRHTY,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.25
CELYHYQECV,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
CELYHYQECV,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
CELYHYQECV,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
CELYHYQECV,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
CELYHYQECV,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
CELYHYQECV,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
CKSKNPLLY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
CKSKNPLLY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
CKSKNPLLY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
CKSKNPLLY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
CKSKNPLLY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
CKSKNPLLY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
CLDAGINYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
CLDAGINYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.07
CLDAGINYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
CLDAGINYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
CLDAGINYV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
CLDAGINYV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
CMTSCCSCLK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
CMTSCCSCLK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
CMTSCCSCLK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),46
CMTSCCSCLK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
CTPPALNCY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
CTPPALNCY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
CTPPALNCY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
CTPPALNCY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
CTPPALNCY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
CTPPALNCY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
CVADYSVLY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
CVADYSVLY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
CVADYSVLY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
CVADYSVLY,HLA-A26:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
CVADYSVLY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
CVADYSVLY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
CVMYASALV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
CVMYASALV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9
CVMYASALV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
CYGVSATKL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
CYGVSATKL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
CYGVSATKL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
CYGVSATKL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
CYGVSATKL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
CYGVSATKL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
CYWPLNDYGF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),48
CYWPLNDYGF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
CYWPLNDYGF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
CYWPLNDYGF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
CYWPLNDYGF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
CYWPLNDYGF,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
DEDDSEPVL,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
DEDDSEPVL,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
DEDDSEPVL,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
DEDDSEPVL,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
DEDDSEPVL,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
DEDDSEPVL,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
DEEPMELDY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
DEEPMELDY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
DEEPMELDY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),49
DEEPMELDY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
DEEPMELDY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
DEEPMELDY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
DLPSGFNTL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,1.2
DLPSGFNTL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,1.2
DLPSGFNTL,HLA-A02:01,T Cell,Negative,51 chromium,cytotoxicity,1.2
DLPSGFNTLK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
DLPSGFNTLK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
DLPSGFNTLK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
DLPSGFNTLK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
DNAFNCTFEY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
DNAFNCTFEY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
DNAFNCTFEY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
DNAFNCTFEY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
DNAFNCTFEY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
DNAFNCTFEY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
DPKVYPIIL,HLA-B07:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
DPKVYPIIL,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
DPKVYPIIL,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
DPKVYPIIL,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
DPKVYPIIL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
DSFKEELDKY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
DSFKEELDKY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),46
DSFKEELDKY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),47
DSFKEELDKY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
DSFKEELDKY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
DSFKEELDKY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
DYSVLYNSTF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),40
DYSVLYNSTF,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
DYSVLYNSTF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
DYSVLYNSTF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
DYSVLYNSTF,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
DYSVLYNSTF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
DYVVVHGYF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
DYVVVHGYF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
DYVVVHGYF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
DYVVVHGYF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
DYVVVHGYF,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
DYVVVHGYF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
ECANLLLQY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
ECANLLLQY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
ECANLLLQY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
ECANLLLQY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
ECANLLLQY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
ECANLLLQY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
EELPDEFVV,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
EELPDEFVV,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
EELPDEFVV,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
EELPDEFVV,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
EELPDEFVV,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
EELPDEFVV,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
EELPDEFVV,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
EELPDEFVV,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
EELPDEFVV,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
EELPDEFVV,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
EELPDEFVV,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
ELCDNPFFA,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.7
ELSPRWYFY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
ELSPRWYFY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
ELSPRWYFY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
ELSPRWYFY,HLA-A26:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
ELSPRWYFY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
ELSPRWYFY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
ELSPRWYFYY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
ELSPRWYFYY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
ELSPRWYFYY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
ELSPRWYFYY,HLA-A26:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
ELSPRWYFYY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
ELSPRWYFYY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
ELYSPLFLI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
ELYSPLFLI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
ELYSPLFLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
ELYSPLFLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
ELYSPLFLI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
ELYSPLFLI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
ETALALLLL,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,12
ETALALLLL,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,18
ETALALLLL,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,8
ETALALLLL,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,55
ETALALLLLD,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,65
ETALALLLLD,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,80
ETALALLLLD,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,65
ETALALLLLD,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,90
ETALALLLLDR,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,90
ETALALLLLDR,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,95
ETALALLLLDR,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,90
ETALALLLLDR,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,100
EVMPVSMAK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
EVMPVSMAK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
EVMPVSMAK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
EVMPVSMAK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
EVMPVSMAK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.4
EVMPVSMAK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.4
EVMPVSMAK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
EVMPVSMAK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
EVMPVSMAK,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
EVMPVSMAK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
EVMPVSMAK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
EVMPVSMAK,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
EVMPVSMAK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
EVMPVSMAK,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),16
EVMPVSMAK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
EVMPVSMAK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
EVMPVSMAK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
EVMPVSMAK,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
EVMPVSMAK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,70
EVMPVSMAK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
EVMPVSMAK,HLA-C04:01,MHC Binding,Positive-Low,purified MHC/competitive/fluorescence,dissociation constant KD,38
EVTPSGTWL,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,7.5
EVTPSGTWLT,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,55
EVTPSGTWLTY,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,70
EYISDAFSL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
EYISDAFSL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
EYISDAFSL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
EYISDAFSL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
EYISDAFSL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
EYISDAFSL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
FADINGKLY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
FADINGKLY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
FADINGKLY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.02
FADINGKLY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.02
FADINGKLY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
FADINGKLY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
FADINGKLY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
FADINGKLY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
FADINGKLY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
FADINGKLY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
FADINGKLY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
FADINGKLY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
FADINGKLY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
FADINGKLY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
FADINGKLY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,38
FADINGKLY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
FADINGKLY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
FADINGKLY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
FADINGKLY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3.5
FADINGKLY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
FADINGKLY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),30
FADINGKLY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
FADINGKLY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
FADINGKLY,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5
FADINGKLY,HLA-C04:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.5
FADINGKLY,HLA-C08:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.12
FDDVQAPNY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
FDDVQAPNY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),60
FDDVQAPNY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),31
FDDVQAPNY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),34
FDDVQAPNY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
FDDVQAPNY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
FEIDKGIYQT,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FEIDKGIYQT,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
FEIDKGIYQT,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
FEIDKGIYQT,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
FEIDKGIYQT,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FEIDKGIYQT,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
FELCDNPFF,HLA-B18:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
FELCDNPFF,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FELCDNPFF,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FELCDNPFF,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
FELCDNPFF,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
FELCDNPFF,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
FELLNAPAT,HLA-B18:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
FELLNAPAT,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
FELLNAPAT,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FELLNAPAT,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
FELLNAPAT,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
FELLNAPAT,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
FERDISNVPF,HLA-B18:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
FERDISNVPF,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
FERDISNVPF,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
FERDISNVPF,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
FERDISNVPF,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
FERDISNVPF,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
FEYISDAFSL,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
FEYISDAFSL,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
FEYISDAFSL,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
FEYISDAFSL,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
FEYISDAFSL,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
FEYISDAFSL,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
FFTLGSITA,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,42
FFTLGSITAQ,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,75
FFTLGSITAQP,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,90
FIAGLIAIV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
FIAGLIAIV,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.17
FIAGLIAIV,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.17
FIAGLIAIV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
FIAGLIAIV,HLA-A02:01,T Cell,Positive,ELISA,IFNg release,0.17
FIAGLIAIV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
FIAGLIAIV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.03
FIAGLIAIV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
FIAGLIAIV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
FICNLLLLFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
FICNLLLLFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
FICNLLLLFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
FICNLLLLFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
FICNLLLLFV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
FICNLLLLFV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
FIFLLFLTL,HLA-A02:01,MHC Binding,Negative,cellular MHC/direct/fluorescence,qualitative binding,0.8
FIFLLFLTL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
FIFLLFLTL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
FIFLLFLTL,HLA-A02:01,T Cell,Negative,51 chromium,cytotoxicity,0.8
FIFLLFLTL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.8
FIFLLFLTL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.8
FIFLLFLTL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
FIFLLFLTL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
FIFLLFLTL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
FIFLLFLTL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
FLAFLLFLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
FLAFLLFLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.04
FLAFLLFLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
FLAFLLFLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
FLAFLLFLV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
FLAFLLFLV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
FLAFLLFLVL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
FLAFLLFLVL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
FLAFLLFLVL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
FLAFLLFLVL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
FLAFLLFLVL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
FLAFLLFLVL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
FLAFVVFLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
FLAFVVFLL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.05
FLAFVVFLL,HLA-A02:01,MHC Binding,Positive,purified MHC,qualitative binding,0.05
FLAFVVFLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
FLAFVVFLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
FLAFVVFLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
FLAFVVFLL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
FLAFVVFLL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.1
FLAFVVFLLV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
FLAFVVFLLV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
FLAFVVFLLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
FLAFVVFLLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
FLAFVVFLLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
FLAFVVFLLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
FLAHLQWFA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
FLAHLQWFA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
FLAHLQWFA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
FLARAIVFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.02
FLARAIVFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.02
FLARAIVFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
FLAVFQSAT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
FLAVFQSAT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
FLAVFQSAT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
FLAVFQSAT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
FLAVFQSAT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9.5
FLAVFQSAT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
FLAVFQSATK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
FLAVFQSATK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
FLAVFQSATK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
FLAVFQSATK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FLCLFLLPSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
FLCLFLLPSL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
FLCLFLLPSL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
FLFLAWIML,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
FLFLAWIML,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
FLFLAWIML,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
FLFLAWIML,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
FLFLAWIML,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
FLFLAWIML,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FLFLAWIMLL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
FLFLAWIMLL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
FLFLAWIMLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
FLFLAWIMLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
FLFLAWIMLL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),2.5
FLFLAWIMLL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FLGRYMSAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
FLGRYMSAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
FLGRYMSAL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),12
FLILCFTIKR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
FLILCFTIKR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
FLILCFTIKR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FLILCFTIKR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
FLITGVFDI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
FLITGVFDI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.125
FLITGVFDI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2
FLIVAALVFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
FLIVAALVFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
FLIVAALVFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
FLIVAALVFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FLIVAALVFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
FLIVAALVFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
FLKEQHCQK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
FLKEQHCQK,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
FLKEQHCQK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
FLKEQHCQK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
FLLFLVLIM,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
FLLFLVLIM,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
FLLFLVLIM,HLA-A02:03,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),2.5
FLLFLVLIM,HLA-A02:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FLLFLVLIM,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
FLLFLVLIM,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),19
FLLFLVLIML,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
FLLFLVLIML,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
FLLFLVLIML,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
FLLFLVLIML,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
FLLFLVLIML,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),6.5
FLLFLVLIML,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
FLLNKEMYL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
FLLNKEMYL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
FLLNKEMYL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),8
FLLPSLATV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
FLLPSLATV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
FLLPSLATV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
FLLVTLAIL,HLA-A02:01,MHC Binding,Positive,purified MHC,qualitative binding,0.15
FLLVTLAIL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
FLLVTLAIL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
FLLVTLAIL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.15
FLLVTLAIL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
FLLVTLAIL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
FLLVTLAIL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
FLLVTLAIL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),10
FLMSFTILCL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
FLMSFTILCL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
FLMSFTILCL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),5
FLNGSCGSV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
FLNGSCGSV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
FLNGSCGSV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9.5
FLNRFTTTL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
FLNRFTTTL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
FLNRFTTTL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
FLNRFTTTL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
FLNRFTTTL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
FLNRFTTTL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
FLPRVFSAV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
FLPRVFSAV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
FLPRVFSAV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
FLTNKLLLFA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
FLTNKLLLFA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
FLTNKLLLFA,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),11
FLTSLLILV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.02
FLTSLLILV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
FLTSLLILV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
FLVLIMLII,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
FLVLIMLII,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
FLVLIMLII,HLA-A02:03,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1.2
FLVLIMLII,HLA-A02:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
FLVLIMLII,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
FLVLIMLII,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
FLWLLWPVT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
FLWLLWPVT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
FLWLLWPVT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
FLWLLWPVT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
FLWLLWPVT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),35
FLWLLWPVT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),35
FLWLLWPVTL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
FLWLLWPVTL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.03
FLWLLWPVTL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.175
FLWLLWPVTL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.175
FLWLLWPVTL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),4.5
FLWLLWPVTL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
FLYIIKLVFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
FLYIIKLVFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
FLYIIKLVFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
FLYIIKLVFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
FLYIIKLVFL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FLYIIKLVFL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),0.7
FLYLYALIY,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
FLYLYALIY,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
FLYLYALIY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
FLYLYALIY,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
FMGRIRSVY,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,1.5
FMGRIRSVY,HLA-B35:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,3.5
FMMSRRRLL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
FMMSRRRLL,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
FMMSRRRLL,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
FMMSRRRLL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
FMMSRRRLL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
FMMSRRRLL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
FMRFFTLGSI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),13
FMRFFTLGSI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
FMRFFTLGSI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
FMRFFTLGSI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
FMRFFTLGSI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),23
FMRFFTLGSI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
FNATKFPSVY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
FNATKFPSVY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
FNATKFPSVY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
FNATKFPSVY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
FNATKFPSVY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
FNATKFPSVY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
FPNITNLCPF,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
FPNITNLCPF,HLA-B35:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
FPNITNLCPF,HLA-B51:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
FPNITNLCPF,HLA-B53:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
FPNITNLCPF,HLA-B54:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
FPPTSFGPL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
FPPTSFGPL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
FPPTSFGPL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
FPPTSFGPL,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),48
FPPTSFGPL,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
FPPTSFGPL,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
FPPTSFGPL,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,85
FPPTSFGPL,HLA-B07:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.2
FPPTSFGPL,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
FPPTSFGPL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.2
FPPTSFGPL,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
FPPTSFGPL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,46
FPPTSFGPL,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,47
FPPTSFGPL,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
FPPTSFGPL,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,1.8
FPPTSFGPL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
FPPTSFGPL,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FPPTSFGPL,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FPPTSFGPL,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FPPTSFGPL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,70
FPPTSFGPL,HLA-C04:01,MHC Binding,Positive-Low,purified MHC/competitive/fluorescence,dissociation constant KD,4
FPPTSFGPL,HLA-C05:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),13
FPPTSFGPL,HLA-C14:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/fluorescence,dissociation constant KD,1.6
FPQAAPHGV,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.9
FPQAAPHGV,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,1.3
FPQAAPHGVV,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
FPQAAPHGVV,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FPQAAPHGVV,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
FPQAAPHGVV,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
FPQAAPHGVV,HLA-B54:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
FPREGVFVF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
FPREGVFVF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
FPREGVFVF,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,8
FPREGVFVF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
FPREGVFVF,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
FPREGVFVF,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.2
FPREGVFVF,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.5
FPREGVFVF,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
FPREGVFVF,HLA-B07:02,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.15
FPREGVFVF,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.15
FPREGVFVF,HLA-B07:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.15
FPREGVFVF,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
FPREGVFVF,HLA-B08:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.4
FPREGVFVF,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.1
FPREGVFVF,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.1
FPREGVFVF,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
FPREGVFVF,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.01
FPREGVFVF,HLA-B35:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
FPREGVFVF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
FPREGVFVF,HLA-B51:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
FPREGVFVF,HLA-B53:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
FPREGVFVF,HLA-B54:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
FPREGVFVF,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
FPREGVFVF,HLA-C07:02,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.15
FPRGQGVPI,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
FPRGQGVPI,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,12
FPRGQGVPI,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
FPRGQGVPI,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
FPRGQGVPI,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,46
FPRGQGVPI,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
FPRGQGVPI,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
FPRGQGVPI,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,38
FPRGQGVPI,HLA-B07:02,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.17
FPRGQGVPI,HLA-B07:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.17
FPRGQGVPI,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
FPRGQGVPI,HLA-B07:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.17
FPRGQGVPI,HLA-B08:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),11
FPRGQGVPI,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
FPRGQGVPI,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
FPRGQGVPI,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
FPRGQGVPI,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,3
FPRGQGVPI,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
FPRGQGVPI,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FPRGQGVPI,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
FPRGQGVPI,HLA-B54:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
FPRGQGVPI,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
FQFICNLLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
FQFICNLLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FQFICNLLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
FQFICNLLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FQFICNLLL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),5
FQFICNLLL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
FQFICNLLLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
FQFICNLLLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
FQFICNLLLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
FQFICNLLLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FQFICNLLLL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
FQFICNLLLL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),9.5
FRYMNSQGL,HLA-C06:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.06
FTERSDKSY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.05
FTERSDKSY,HLA-B35:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,8
FTIAMWLLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
FTIAMWLLL,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
FTIAMWLLL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
FTLGIMAIA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
FTLGIMAIA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
FTLGIMAIA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
FTLGSITAQ,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,16
FTLGSITAQP,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,21
FTLGSITAQPV,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,60
FTLLFQLCT,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),14
FTLLFQLCT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),37
FTLLFQLCT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),20
FTNDVSFLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
FTNDVSFLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
FTNDVSFLA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
FTSCELYHY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
FTSCELYHY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
FTSCELYHY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
FTSCELYHY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
FTSCELYHY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
FTSCELYHY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
FTTSLSLHK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
FTTSLSLHK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
FTTSLSLHK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
FTTSLSLHK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
FTYASALWEI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
FTYASALWEI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
FTYASALWEI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
FVASFRLFA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
FVASFRLFA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
FVASFRLFA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
FVASFRLFA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
FVASFRLFA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
FVASFRLFA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
FVASFRLFAR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
FVASFRLFAR,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FVASFRLFAR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FVASFRLFAR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
FVDEFYAYL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
FVDEFYAYL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
FVDEFYAYL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
FVDGVPFVV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.08
FVDGVPFVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
FVDGVPFVV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
FVDGVPFVV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.125
FVFNGTSWFI,HLA-A02:01,MHC Binding,Positive,cellular MHC/competitive/fluorescence,qualitative binding,2.5
FVFNGTSWFI,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,2.5
FVFNGTSWFI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
FVFNGTSWFI,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,2.5
FVFNGTSWFI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FVFNGTSWFI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
FVFNGTSWFI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
FVFNGTSWFI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
FVFNGTSWFI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
FVLAAVYRI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
FVLAAVYRI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
FVLAAVYRI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
FVLAAVYRI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FVLAAVYRI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
FVLAAVYRI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
FVTIYSHLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FVTIYSHLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
FVTIYSHLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
FVTIYSHLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
FVTIYSHLL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
FVTIYSHLL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
FVVFLLVTL,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
FVVFLLVTL,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
FVVFLLVTL,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
FVVFLLVTL,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
FVVFLLVTL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
FVVFLLVTL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
FYLCFLAFL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
FYLCFLAFL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
FYLCFLAFL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
FYLCFLAFL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
FYLCFLAFL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
FYLCFLAFL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
FYLCFLAFLL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
FYLCFLAFLL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
FYLCFLAFLL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
FYLCFLAFLL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),46
FYLCFLAFLL,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
FYLCFLAFLL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
FYTTTGIGY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
FYTTTGIGY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
FYTTTGIGY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
FYTTTGIGY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
FYTTTGIGY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
FYTTTGIGY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
GAEHVDTSY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
GAEHVDTSY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),37
GAEHVDTSY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),44
GAEHVDTSY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
GAEHVDTSY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
GAEHVDTSY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
GALDVSASV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
GALDVSASV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
GALDVSASV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
GEILLLEWL,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
GEILLLEWL,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
GEILLLEWL,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
GEILLLEWL,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
GEILLLEWL,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
GEILLLEWL,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
GEILLLEWLA,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
GEILLLEWLA,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
GEILLLEWLA,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
GEILLLEWLA,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
GEILLLEWLA,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
GEILLLEWLA,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GETALALLL,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,11
GETALALLL,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,15
GETALALLL,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
GETALALLL,HLA-B40:01,MHC Binding,Positive,purified MHC,qualitative binding,0.1
GETALALLL,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
GETALALLL,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
GETALALLL,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
GETALALLL,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
GETALALLL,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
GETALALLL,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,65
GETALALLLL,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,11
GETALALLLL,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,19
GETALALLLL,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
GETALALLLL,HLA-B40:01,T Cell,Positive,ICS,CCL4/MIP-1b release,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive,ICS,CCL3/MIP-1a release,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive,ICS,IFNg release,0.25
GETALALLLL,HLA-B40:01,MHC Binding,Positive,purified MHC,qualitative binding,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive,ELISPOT,IFNg release,0.25
GETALALLLL,HLA-B40:01,T Cell,Negative,ICS,IL-4 release,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive-Low,ICS,IL-8 release,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive-Low,ICS,GM-CSF release,0.25
GETALALLLL,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
GETALALLLL,HLA-B40:01,T Cell,Positive,ICS,IL-2 release,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive,multimer/tetramer,qualitative binding,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive,biological activity,degranulation,0.25
GETALALLLL,HLA-B40:01,T Cell,Negative,ICS,IL-10 release,0.25
GETALALLLL,HLA-B40:01,T Cell,Positive,ICS,TNFa release,0.25
GETALALLLL,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
GETALALLLL,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
GETALALLLL,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
GETALALLLL,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
GETALALLLL,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,85
GETALALLLLD,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,70
GETALALLLLD,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,85
GETALALLLLD,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,6
GETALALLLLD,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,100
GETALALLLLDRLNQ,HLA-A02:01,MHC Binding,Positive,purified MHC,qualitative binding,100
GETALALLLLDRLNQ,HLA-A02:07,MHC Binding,Positive,purified MHC,qualitative binding,100
GETALALLLLDRLNQ,HLA-B40:01,MHC Binding,Positive,purified MHC,qualitative binding,36
GETALALLLLDRLNQ,HLA-B46:01,MHC Binding,Positive,purified MHC,qualitative binding,100
GEVFNATKF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,41
GEVFNATKF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,37
GEVFNATKF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
GEVFNATKF,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
GEVFNATKF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
GEVFNATKF,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.8
GEVFNATKF,HLA-B40:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.2
GEVFNATKF,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
GFAAYNRYR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
GFAAYNRYR,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
GFAAYNRYR,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GFAAYNRYR,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
GFNTLKPIFK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
GFNTLKPIFK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
GFNTLKPIFK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
GFNTLKPIFK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
GLIAIVMVTI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GLIAIVMVTI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
GLIAIVMVTI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.175
GLIAIVMVTI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.175
GLIAIVMVTI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
GLIAIVMVTI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
GLMWLSYFV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
GLMWLSYFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.04
GLMWLSYFV,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.04
GLMWLSYFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.04
GLMWLSYFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
GLMWLSYFV,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.04
GLMWLSYFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
GLMWLSYFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
GLMWLSYFV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),16
GLMWLSYFV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
GLMWLSYFV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
GLMWLSYFV,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
GLMWLSYFV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,27
GLMWLSYFV,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
GLMWLSYFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
GLMWLSYFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
GLMWLSYFV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
GLMWLSYFV,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
GLMWLSYFV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
GLMWLSYFV,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
GLMWLSYFV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
GLMWLSYFV,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,42
GLMWLSYFVA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
GLMWLSYFVA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
GLMWLSYFVA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
GLMWLSYFVA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
GLMWLSYFVA,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),42
GLMWLSYFVA,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),42
GLSDRVVFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
GLSDRVVFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
GLSDRVVFV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
GMEAQFLYL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
GMEAQFLYL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
GMEAQFLYL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
GMEAQFLYL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
GMEAQFLYL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),12
GMEAQFLYL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
GMEAQFLYLY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
GMEAQFLYLY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
GMEAQFLYLY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),35
GMEAQFLYLY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
GMEAQFLYLY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
GMEAQFLYLY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
GMEVTPSGT,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,14
GMEVTPSGTW,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,12
GMEVTPSGTWL,HLA-B40:01,MHC Binding,Positive,purified MHC,qualitative binding,5
GMKRSFYVY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
GMKRSFYVY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
GMKRSFYVY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
GMKRSFYVY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),8.5
GMKRSFYVY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,8.5
GMKRSFYVY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
GMKRSFYVY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),16
GMKRSFYVY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
GMKRSFYVY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
GMKRSFYVY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
GMKRSFYVY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
GMKRSFYVY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
GMKRSFYVY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
GMKRSFYVY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
GMKRSFYVY,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
GMKRSFYVY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,33
GMKRSFYVY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
GMKRSFYVY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.25
GMKRSFYVY,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.25
GMKRSFYVY,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.25
GMKRSFYVY,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),10
GMKRSFYVY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
GMKRSFYVY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
GMSRIGMEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/fluorescence,dissociation constant KD,1.1
GMSRIGMEV,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,1.1
GMSRIGMEV,HLA-A02:01,T Cell,Positive,ELISA,IFNg release,1.1
GMSRIGMEV,HLA-A02:01,T Cell,Positive-Intermediate,ELISPOT,IFNg release,1.1
GMSRIGMEV,HLA-A02:01,MHC Binding,Positive-High,cellular MHC/direct/fluorescence,qualitative binding,1.1
GMSRIGMEV,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,1.1
GMSRIGMEV,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.1
GPDDQIGYY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
GPDDQIGYY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),41
GPDDQIGYY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),34
GPDDQIGYY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
GPDDQIGYY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GPDDQIGYY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
GPQSNQRSA,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
GPQSNQRSA,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
GPQSNQRSA,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
GPQSNQRSA,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
GPQSNQRSA,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
GQGQNSADPK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
GQGQNSADPK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
GQGQNSADPK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),48
GQGQNSADPK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
GQQQQGQTV,HLA-A02:01,MHC Binding,Negative,cellular MHC/direct/fluorescence,qualitative binding,3
GQTGVIADY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
GQTGVIADY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),13
GQTGVIADY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
GQTGVIADY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
GQTGVIADY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
GQTGVIADY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
GQTGVIADY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
GQTGVIADY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
GQTGVIADY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
GQTGVIADY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,49
GQTGVIADY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.05
GQTGVIADY,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.05
GQTGVIADY,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.05
GQTGVIADY,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.7
GQTGVIADY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
GQTGVIADY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
GRLQSLQTY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
GRLQSLQTY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
GRLQSLQTY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
GRLQSLQTY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
GRLQSLQTY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
GRLQSLQTY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
GRLQSLQTY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
GRLQSLQTY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
GRLQSLQTY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1
GRLQSLQTY,HLA-B27:05,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
GRLQSLQTY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
GRLQSLQTY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
GSFCTQLNR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
GSFCTQLNR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
GSFCTQLNR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
GSFCTQLNR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
GSITAQPVK,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,5
GSITAQPVKI,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,5.5
GTDSGFAAY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
GTDSGFAAY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.02
GTDSGFAAY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
GTDSGFAAY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
GTDSGFAAY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
GTDSGFAAY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1
GTDSGFAAY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1
GTDSGFAAY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1
GTDSGFAAY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,1
GTDSGFAAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),40
GTDSGFAAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
GTDSGFAAY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
GTDSGFAAY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
GTDSGFAAY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.9
GTDSGFAAY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
GTDSGFAAY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
GTDSGFAAY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
GTDSGFAAY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
GTDSGFAAY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
GTDSGFAAY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.9
GTDSGFAAY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
GTDSGFAAY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
GTDSGFAAY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.2
GTDSGFAAY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.2
GTGPEASLPY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
GTGPEASLPY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),50
GTGPEASLPY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),39
GTGPEASLPY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
GTGPEASLPY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
GTGPEASLPY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
GTLSYDNLK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
GTLSYDNLK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
GTLSYDNLK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
GTLSYDNLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.08
GTLSYDNLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.08
GTLSYDNLK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,70
GTLSYDNLK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,49
GTLSYDNLK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
GTLSYDNLK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
GTSAAAYFV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
GTSAAAYFV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
GTSAAAYFV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
GTSAAAYFV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),14
GTSAAAYFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
GTSAAAYFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
GTSWFITQR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
GTSWFITQR,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
GTSWFITQR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
GTSWFITQR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
GTTLPKGFY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GTTLPKGFY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),65
GTTLPKGFY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
GTTLPKGFY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
GTTLPKGFY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GTTLPKGFY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
GVAMPNLYK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
GVAMPNLYK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
GVAMPNLYK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
GVAMPNLYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.03
GVAMPNLYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
GVAMPNLYK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.03
GVAMPNLYK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
GVAMPNLYK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
GVIADYNYK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
GVIADYNYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
GVIADYNYK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
GVIADYNYK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
GVVFLHVTY,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
GVVFLHVTY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
GVVFLHVTY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
GVVFLHVTY,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
GVYDYLVST,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
GVYDYLVST,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
GVYDYLVST,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1.2
GVYYPDEIFR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GVYYPDEIFR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
GVYYPDEIFR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GVYYPDEIFR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
GYLKPTTFM,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
GYLKPTTFM,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
GYLKPTTFM,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
GYLKPTTFM,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
GYLKPTTFM,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
GYLKPTTFM,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
GYLKPTTFML,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),65
GYLKPTTFML,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
GYLKPTTFML,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
GYLKPTTFML,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
GYLKPTTFML,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
GYLKPTTFML,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
GYQPYRVVVL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
GYQPYRVVVL,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
GYQPYRVVVL,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
GYQPYRVVVL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),35
GYQPYRVVVL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
GYQPYRVVVL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
HADQLTPAW,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
HADQLTPAW,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
HADQLTPAW,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
HADQLTPAW,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),22
HADQLTPAW,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
HADQLTPAW,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
HADQLTPAW,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
HADQLTPAW,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),8.5
HADQLTPAW,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
HADQLTPAW,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
HADQLTPAW,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
HADQLTPAW,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,36
HADQLTPAW,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.5
HADQLTPAW,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
HADQLTPAW,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.125
HADQLTPAW,HLA-B58:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.125
HAFLCLFLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
HAFLCLFLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
HAFLCLFLL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
HEGHQTAAF,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
HEGHQTAAF,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
HEGHQTAAF,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
HEGHQTAAF,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
HEGHQTAAF,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
HEGHQTAAF,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
HLDGEVLSL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.04
HLDGEVLSL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
HLDGEVLSL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),2.5
HLVDFQVTI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
HLVDFQVTI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
HLVDFQVTI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
HLVDFQVTI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
HLVDFQVTI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
HLVDFQVTI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.07
HPLADNKFAL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
HPLADNKFAL,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
HPLADNKFAL,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
HPLADNKFAL,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
HPLADNKFAL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
HPLSHFVNL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,40
HPLSHFVNL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
HPLSHFVNL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
HPLSHFVNL,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),13
HPLSHFVNL,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
HPLSHFVNL,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
HPLSHFVNL,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
HPLSHFVNL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.15
HPLSHFVNL,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.15
HPLSHFVNL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.15
HPLSHFVNL,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
HPLSHFVNL,HLA-B08:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
HPLSHFVNL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
HPLSHFVNL,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4
HPLSHFVNL,HLA-B35:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.15
HPLSHFVNL,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
HPLSHFVNL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
HPLSHFVNL,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
HPLSHFVNL,HLA-B53:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
HPLSHFVNL,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
HPLSHFVNL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
HQNSKKTTK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
HQNSKKTTK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
HQNSKKTTK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
HQNSKKTTK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
HTLESPVEF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
HTLESPVEF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
HTLESPVEF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.1
HTLESPVEF,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.4
HTLESPVEF,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.6
HTLESPVEF,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.5
HTLESPVEF,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
HTLESPVEF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
HTLESPVEF,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
HTLESPVEF,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
HTLESPVEF,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.7
HTLESPVEF,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
HTLESPVEF,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.4
HTLESPVEF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
HTLESPVEF,HLA-B58:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.15
HTLESPVEF,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.15
HTLESPVEF,HLA-C04:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.3
HTSSMRGVY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
HTSSMRGVY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
HTSSMRGVY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
HTSSMRGVY,HLA-A26:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
HTSSMRGVY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
HTSSMRGVY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
HTSSMRGVYY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
HTSSMRGVYY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),40
HTSSMRGVYY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),41
HTSSMRGVYY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
HTSSMRGVYY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
HTSSMRGVYY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
IAACAMLLV,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
IAACAMLLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
IAACAMLLV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
IAMWLLLLSI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),15
IAMWLLLLSI,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
IAMWLLLLSI,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),7
IDATSTGNY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
IDATSTGNY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
IDATSTGNY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
IDATSTGNY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
IDATSTGNY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
IDATSTGNY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
IDFYLCFLAF,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
IDFYLCFLAF,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
IDFYLCFLAF,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
IDFYLCFLAF,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
IDFYLCFLAF,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
IDFYLCFLAF,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),34
IENATFFIF,HLA-B18:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
IENATFFIF,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
IENATFFIF,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
IENATFFIF,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
IENATFFIF,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
IENATFFIF,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
IFRSDTLYL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
IFRSDTLYL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
IFRSDTLYL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
IFRSDTLYL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
IFRSDTLYL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
IFRSDTLYL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
IGAGICASY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
IGAGICASY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
IGAGICASY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
IGAGICASY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
IGAGICASY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
IGAGICASY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
IGMEVTPSG,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,37
IGMEVTPSGT,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,55
IGMEVTPSGTW,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,50
IGMEVTPSGTWLTYH,HLA-B40:01,MHC Binding,Positive,purified MHC,qualitative binding,85
IIFWFSLEI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
IIFWFSLEI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
IIFWFSLEI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
IIFWFSLEI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
IIFWFSLEI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
IIFWFSLEI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
IIMRCWLCWK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
IIMRCWLCWK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
IIMRCWLCWK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
IIMRCWLCWK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
IITTDNTFV,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,1.7
ILASFSAST,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
ILASFSAST,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
ILASFSAST,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
ILCFTIKRK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
ILCFTIKRK,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
ILCFTIKRK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
ILCFTIKRK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
ILFLTLIVFT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
ILFLTLIVFT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
ILFLTLIVFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
ILFLTLIVFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
ILFLTLIVFT,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),13
ILFLTLIVFT,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
ILGLPTQTV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
ILGLPTQTV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
ILGLPTQTV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
ILGLPTQTV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
ILGLPTQTV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
ILGLPTQTV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2
ILGLPTQTV,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2
ILGLPTQTV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
ILGTVSWNL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
ILGTVSWNL,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
ILGTVSWNL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
ILGTVSWNL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.4
ILGTVSWNL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
ILGTVSWNL,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
ILGTVSWNL,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1
ILGTVSWNL,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
ILGTVSWNL,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
ILGTVSWNL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
ILGTVSWNL,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
ILGTVSWNL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
ILGTVSWNL,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
ILGTVSWNL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
ILGTVSWNL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
ILGTVSWNL,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
ILHCANFNV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
ILHCANFNV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
ILHCANFNV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ILHCANFNV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
ILHCANFNV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
ILHCANFNV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.4
ILHCANFNV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
ILHCANFNV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
ILHCANFNV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),19
ILHCANFNV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
ILHCANFNV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
ILHCANFNV,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
ILHCANFNV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,38
ILHCANFNV,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),21
ILHCANFNV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),11
ILHCANFNV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
ILHCANFNV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,35
ILHCANFNV,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,33
ILHCANFNV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
ILHCANFNV,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
ILHCANFNV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
ILHCANFNV,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
ILLAPLLSA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
ILLAPLLSA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
ILLAPLLSA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
ILLAPLLSA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
ILLAPLLSA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),21
ILLAPLLSA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
ILLCCMTSC,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,3.5
ILLLDQVLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.1
ILLLDQVLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
ILLLDQVLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
ILLLDQVLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
ILLLDQVLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
ILLLDQVLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
ILLNKHID,HLA-A02:01,T Cell,Positive-Low,ELISPOT,IFNg release,12
ILLNKHID,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,12
ILLNKHIDA,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.7
ILLNKHIDA,HLA-A02:01,MHC Binding,Positive-Intermediate,cellular MHC/direct/fluorescence,qualitative binding,0.7
ILLNKHIDA,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.7
ILLNKHIDA,HLA-A02:01,MHC Binding,Negative,cellular MHC/direct/fluorescence,qualitative binding,0.7
ILPDPLKPT,HLA-A02:01,T Cell,Positive,ELISA,IFNg release,1.5
ILPDPLKPT,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,1.5
IMLIIFWFSL,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
IMLIIFWFSL,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
IMLIIFWFSL,HLA-A02:03,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),18
IMLIIFWFSL,HLA-A02:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
IMLIIFWFSL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
IMLIIFWFSL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),17
IMQVFFGYFA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),13
IMQVFFGYFA,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),34
IMQVFFGYFA,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),47
IPLQASLPF,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
IPLQASLPF,HLA-B35:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
IPLQASLPF,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
IPLQASLPF,HLA-B53:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
IPLQASLPF,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
IPRRNVATL,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,14
IPRRNVATL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.06
IPRRNVATL,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,1
IPTNFSISI,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
IPTNFSISI,HLA-B35:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
IPTNFSISI,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
IPTNFSISI,HLA-B53:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
IPTNFSISI,HLA-B54:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
IQDLEEPCTK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
IQDLEEPCTK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
IQDLEEPCTK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
IQDLEEPCTK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),31
IQFMMSRRR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
IQFMMSRRR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
IQFMMSRRR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
IQFMMSRRR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
IQPGQTFSV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
IQPGQTFSV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
IQPGQTFSV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
ISDYDYYRY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
ISDYDYYRY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.01
ISDYDYYRY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
ISDYDYYRY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
ISDYDYYRY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
ISDYDYYRY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
ISDYDYYRY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
ISDYDYYRY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
ISDYDYYRY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
ISDYDYYRY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
ISDYDYYRY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
ISDYDYYRY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,65
ISDYDYYRY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
ISDYDYYRY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
ISDYDYYRY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.08
ISTPKLKEDY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
ISTPKLKEDY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
ISTPKLKEDY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
ISTPKLKEDY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
ISTPKLKEDY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
ISTPKLKEDY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
ITAIYVFCI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),13
ITAIYVFCI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
ITAIYVFCI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
ITCVVIPSK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
ITCVVIPSK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
ITCVVIPSK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
ITCVVIPSK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.25
ITCVVIPSK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.25
ITCVVIPSK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
ITCVVIPSK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
ITCVVIPSK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,42
ITCVVIPSK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
ITMTTVYHI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
ITMTTVYHI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
ITMTTVYHI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9
ITMTTVYHI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
ITMTTVYHI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
ITMTTVYHI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
IVAALVFLI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
IVAALVFLI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
IVAALVFLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
IVAALVFLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
IVAALVFLI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.09
IVAALVFLI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
IVDTVSALV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
IVDTVSALV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
IVDTVSALV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
IVNSVLLFL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
IVNSVLLFL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
IVNSVLLFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
IVNSVLLFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
IVNSVLLFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
IVNSVLLFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
IVWVATEGA,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,5.5
IYSTGNNVF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
IYSTGNNVF,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
IYSTGNNVF,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
IYSTGNNVF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
IYSTGNNVF,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
IYSTGNNVF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
KCYGVSATK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,43
KCYGVSATK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
KCYGVSATK,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,0.3
KCYGVSATK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.3
KCYGVSATK,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.8
KCYGVSATK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.8
KCYGVSATK,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
KCYGVSATK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
KCYGVSATK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3.5
KCYGVSATK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
KCYGVSATK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,60
KCYGVSATK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
KCYGVSATK,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.3
KCYGVSATK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
KCYGVSATK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
KDYVVVHGYF,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
KDYVVVHGYF,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
KDYVVVHGYF,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
KDYVVVHGYF,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
KDYVVVHGYF,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
KDYVVVHGYF,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),80
KEDYQIGGY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KEDYQIGGY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),37
KEDYQIGGY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),48
KEDYQIGGY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
KEDYQIGGY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
KEDYQIGGY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
KEGIVWVAT,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
KEGIVWVAT,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
KEGIVWVAT,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
KEGIVWVAT,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
KEGIVWVAT,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
KEGIVWVAT,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
KELSPRWYF,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
KELSPRWYF,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
KELSPRWYF,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
KELSPRWYF,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
KELSPRWYF,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
KELSPRWYF,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
KELSPRWYFY,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
KELSPRWYFY,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
KELSPRWYFY,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
KELSPRWYFY,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
KELSPRWYFY,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
KELSPRWYFY,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
KEPCPSGTY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
KEPCPSGTY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
KEPCPSGTY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
KEPCPSGTY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
KEPCPSGTY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
KEPCPSGTY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
KEPCPSGTY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.1
KEPCPSGTY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
KFTTSLSLHK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
KFTTSLSLHK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
KFTTSLSLHK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
KFTTSLSLHK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
KIILFLTLI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
KIILFLTLI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
KIILFLTLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KIILFLTLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
KIILFLTLI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
KIILFLTLI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
KISNCVADY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
KISNCVADY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
KISNCVADY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
KISNCVADY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
KISNCVADY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
KISNCVADY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
KLFAAETLK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
KLFAAETLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
KLFAAETLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.5
KLFAAETLK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
KLFAAETLK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
KLFAAETLK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
KLFAAETLK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
KLFIRQEEV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
KLFIRQEEV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.1
KLFIRQEEV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.1
KLFIRQEEV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.1
KLFIRQEEV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
KLFIRQEEV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
KLFIRQEEV,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
KLFIRQEEV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
KLFIRQEEV,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),7.5
KLFIRQEEV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
KLFIRQEEV,HLA-B08:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
KLFIRQEEV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.4
KLFIRQEEV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.4
KLFIRQEEV,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
KLFIRQEEV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
KLFIRQEEV,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
KLFTIAMWL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
KLFTIAMWL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
KLFTIAMWL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
KLFTIAMWLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
KLFTIAMWLL,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
KLFTIAMWLL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),5.5
KLIEYSDFA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
KLIEYSDFA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
KLIEYSDFA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),19
KLLIVLTCI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KLLIVLTCI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
KLLIVLTCI,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
KLLIVLTCI,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
KLLIVLTCI,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
KLLIVLTCI,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),25
KLLQTLVLK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
KLLQTLVLK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.175
KLLQTLVLK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KLLQTLVLK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
KLMGHFSWWT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
KLMGHFSWWT,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),13
KLMGHFSWWT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),65
KLMPICMDV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
KLMPICMDV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
KLMPICMDV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.08
KLMPICMDV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.08
KLMPICMDV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
KLMPICMDV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.08
KLMPICMDV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
KLMPICMDV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
KLMPICMDV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
KLMPICMDV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
KLMPICMDV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
KLMPICMDV,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
KLMPICMDV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
KLMPICMDV,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
KLMPICMDV,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
KLMPICMDV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),7
KLMPICMDV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
KLMPICMDV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),17
KLMPICMDV,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
KLMPICMDV,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
KLMPICMDV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
KLMPICMDV,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
KLMPICMDV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
KLMPICMDV,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
KLNDLCFSNV,HLA-A02:01,MHC Binding,Positive,cellular MHC/competitive/fluorescence,qualitative binding,0.4
KLNDLCFSNV,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.4
KLNDLCFSNV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
KLNVGDYFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
KLNVGDYFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
KLNVGDYFV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),13
KLPDDFMGC,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,1
KLPDDFMGCV,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,1
KLPDDFMGCV,HLA-A02:01,T Cell,Positive,multimer/tetramer,qualitative binding,1
KLPDDFMGCV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,1
KLPDDFMGCV,HLA-A02:01,MHC Binding,Positive,cellular MHC/competitive/fluorescence,qualitative binding,1
KLSYGIATV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
KLSYGIATV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
KLSYGIATV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
KLWAQCVQL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
KLWAQCVQL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
KLWAQCVQL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.05
KLWAQCVQL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.05
KLWAQCVQL,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.05
KLWAQCVQL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
KLWAQCVQL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
KLWAQCVQL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KLWAQCVQL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.9
KLWAQCVQL,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.9
KLWAQCVQL,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
KLWAQCVQL,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
KLWAQCVQL,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
KLWAQCVQL,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
KLWAQCVQL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),12
KLWAQCVQL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
KLWAQCVQL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
KLWAQCVQL,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
KLWAQCVQL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.6
KLWAQCVQL,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
KLWAQCVQL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
KLWAQCVQL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
KMKELSPRW,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
KMKELSPRW,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
KMKELSPRW,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
KMKELSPRW,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),9
KMKELSPRW,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),26
KMKELSPRW,HLA-A24:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,1.6
KMKELSPRW,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
KMKELSPRW,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
KMKELSPRW,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
KMKELSPRW,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,44
KMKELSPRW,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
KMKELSPRW,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
KMKELSPRW,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),17
KMKELSPRW,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
KMKELSPRW,HLA-B58:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.09
KMKELSPRW,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.09
KMQRMLLEK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KMQRMLLEK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.6
KMQRMLLEK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.6
KMQRMLLEK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.4
KMQRMLLEK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,1.4
KMQRMLLEK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
KMQRMLLEK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
KMQRMLLEK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
KPASRELSV,HLA-B07:02,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.3
KPASRELSV,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
KPASRELSV,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
KPASRELSV,HLA-B35:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,8.5
KPASRELSV,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
KPASRELSV,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
KPASRELSV,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
KPLLAPHHVV,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
KPLLAPHHVV,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
KPLLAPHHVV,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
KPLLAPHHVV,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
KPLLAPHHVV,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
KPTTFMLKY,HLA-B07:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
KPTTFMLKY,HLA-B35:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
KPTTFMLKY,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
KPTTFMLKY,HLA-B53:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
KPTTFMLKY,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
KQFDTYNLW,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
KQFDTYNLW,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
KQFDTYNLW,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),7
KQFDTYNLW,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.8
KQFDTYNLW,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
KQFDTYNLW,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.8
KQFDTYNLW,HLA-A24:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.8
KQFDTYNLW,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
KQFDTYNLW,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1
KQFDTYNLW,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,37
KQFDTYNLW,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,44
KQFDTYNLW,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
KQFDTYNLW,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
KQFDTYNLW,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
KQFDTYNLW,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
KQFDTYNLW,HLA-B58:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.03
KQFDTYNLW,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.03
KQIANQFNK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KQIANQFNK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
KQIANQFNK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
KQIANQFNK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
KQMYKTPTLK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
KQMYKTPTLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
KQMYKTPTLK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
KQMYKTPTLK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
KQYNVTQAF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,36
KQYNVTQAF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
KQYNVTQAF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),11
KQYNVTQAF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.8
KQYNVTQAF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.8
KQYNVTQAF,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),13
KQYNVTQAF,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.8
KQYNVTQAF,HLA-A24:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.8
KQYNVTQAF,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
KQYNVTQAF,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4
KQYNVTQAF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
KQYNVTQAF,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
KQYNVTQAF,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
KQYNVTQAF,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
KQYNVTQAF,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.01
KQYNVTQAF,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.4
KQYNVTQAF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
KQYNVTQAF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
KQYNVTQAF,HLA-B46:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/fluorescence,dissociation constant KD,0.04
KQYNVTQAF,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.12
KQYNVTQAF,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.12
KQYNVTQAF,HLA-C14:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.9
KRFQPFQQF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,43
KRFQPFQQF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
KRFQPFQQF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3.5
KRFQPFQQF,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),9
KRFQPFQQF,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
KRFQPFQQF,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
KRFQPFQQF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
KRFQPFQQF,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,33
KRFQPFQQF,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.175
KRFQPFQQF,HLA-B27:05,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
KRFQPFQQF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
KRFQPFQQF,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
KRVDWSVEY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
KRVDWSVEY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
KRVDWSVEY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
KRVDWSVEY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
KRVDWSVEY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
KRVDWSVEY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
KRVDWSVEY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,27
KRVDWSVEY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,42
KRVDWSVEY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.09
KRVDWSVEY,HLA-B27:05,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
KRVDWSVEY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
KRVDWSVEY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.6
KRVDWSVEY,HLA-C07:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
KSFEIDKGIY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
KSFEIDKGIY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),41
KSFEIDKGIY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),36
KSFEIDKGIY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
KSFEIDKGIY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
KSFEIDKGIY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
KSFNHVLKRK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
KSFNHVLKRK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
KSFNHVLKRK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
KSFNHVLKRK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
KSKSFNHVLK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
KSKSFNHVLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
KSKSFNHVLK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
KSKSFNHVLK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
KSYEHQTPF,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.4
KSYEHQTPF,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,18
KSYEHQTPF,HLA-B46:01,MHC Binding,Positive-High,purified MHC/competitive/fluorescence,dissociation constant KD,0.09
KSYEHQTPF,HLA-C03:03,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.1
KSYEHQTPF,HLA-C08:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3.5
KSYEHQTPF,HLA-C12:03,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1
KSYEHQTPF,HLA-C14:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
KSYEHQTPF,HLA-C15:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.3
KTFPPTEPK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
KTFPPTEPK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
KTFPPTEPK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
KTFPPTEPK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
KTFPPTEPK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
KTFPPTEPK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
KTFPPTEPK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.07
KTFPPTEPK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.07
KTFPPTEPK,HLA-A11:01,MHC Binding,Positive,x-ray crystallography,3D structure,0.07
KTFPPTEPK,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
KTFPPTEPK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
KTFPPTEPK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
KTFPPTEPK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.6
KTFPPTEPK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
KTFPPTEPK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
KTFPPTEPK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
KTFPPTEPK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
KTFPPTEPK,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
KTFPPTEPK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
KTFPPTEPK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
KTFPPTEPKK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
KTFPPTEPKK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
KTFPPTEPKK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
KTFPPTEPKK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
KTSVDCNMY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
KTSVDCNMY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
KTSVDCNMY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
KTSVDCNMY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
KTSVDCNMY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
KTSVDCNMY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
KVIQPRVEK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.1
KVIQPRVEK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.08
LAFVVFLLV,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
LAFVVFLLV,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
LAFVVFLLV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
LAFVVFLLV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LAFVVFLLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
LAFVVFLLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LALLLLDRL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,11
LALLLLDRL,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,11
LALLLLDRL,HLA-A02:01,MHC Binding,Positive-High,cellular MHC/direct/fluorescence,qualitative binding,11
LALLLLDRL,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,11
LALLLLDRL,HLA-A02:01,T Cell,Positive-High,ELISPOT,IFNg release,11
LALLLLDRL,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,4.5
LALLLLDRL,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,7
LALLLLDRL,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,33
LALLLLDRLN,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,70
LALLLLDRLN,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,65
LALLLLDRLN,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,70
LALLLLDRLN,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,80
LALLLLDRLNQ,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,80
LALLLLDRLNQ,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,80
LALLLLDRLNQ,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,90
LALLLLDRLNQ,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,90
LAMSTTISV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LAMSTTISV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LAMSTTISV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LEQWNLVIGF,HLA-B18:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
LEQWNLVIGF,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
LEQWNLVIGF,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LEQWNLVIGF,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
LEQWNLVIGF,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LEQWNLVIGF,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LEWLAEVVKL,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
LEWLAEVVKL,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
LEWLAEVVKL,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LEWLAEVVKL,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
LEWLAEVVKL,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LEWLAEVVKL,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
LFAGTHITM,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
LFAGTHITM,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LFAGTHITM,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
LFAGTHITM,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
LFAGTHITM,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
LFAGTHITM,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
LFARTRSMW,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
LFARTRSMW,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
LFARTRSMW,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
LFARTRSMW,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),44
LFARTRSMW,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
LFARTRSMW,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
LFLAFVVFL,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
LFLAFVVFL,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LFLAFVVFL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LFLAFVVFL,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
LFLAFVVFL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
LFLAFVVFL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),31
LFLAFVVFLL,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
LFLAFVVFLL,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
LFLAFVVFLL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
LFLAFVVFLL,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),60
LFLAFVVFLL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
LFLAFVVFLL,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
LFLIVAALVF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
LFLIVAALVF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
LFLIVAALVF,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
LFLIVAALVF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),35
LFLIVAALVF,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LFLIVAALVF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
LFVTIYSHL,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
LFVTIYSHL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LFVTIYSHL,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
LFVTIYSHL,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
LFVTIYSHL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
LFVTIYSHL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
LGADSSIAY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
LGADSSIAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
LGADSSIAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
LGADSSIAY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
LGADSSIAY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
LGADSSIAY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
LGSITAQPV,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,41
LGSITAQPVK,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,45
LGSITAQPVKI,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,50
LIANIFTPLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
LIANIFTPLV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
LIANIFTPLV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
LIDFYLCFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
LIDFYLCFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
LIDFYLCFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
LIDFYLCFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
LIDFYLCFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),10
LIDFYLCFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
LIDLQELGKY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
LIDLQELGKY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),70
LIDLQELGKY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),55
LIDLQELGKY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
LIDLQELGKY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
LIDLQELGKY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
LIGANYLGK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.4
LIGANYLGK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
LIGANYLGK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LIGANYLGK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.8
LIGANYLGK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
LIGANYLGK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
LIGANYLGK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LILCFTIKR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LILCFTIKR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LILCFTIKR,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
LILCFTIKR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
LITGRLQSL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,3
LITGRLQSL,HLA-A02:01,T Cell,Positive,ELISA,IFNg release,3
LITGRLQSL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,3
LIVAALVFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
LIVAALVFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
LIVAALVFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
LIVAALVFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
LIVAALVFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LIVAALVFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
LIVNSVLLFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
LIVNSVLLFL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,6
LIVNSVLLFL,HLA-A02:01,MHC Binding,Positive,purified MHC,qualitative binding,6
LIVNSVLLFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
LIVNSVLLFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
LIVNSVLLFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LIVNSVLLFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
LIVNSVLLFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
LKEPCPSGTY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
LKEPCPSGTY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
LKEPCPSGTY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),41
LKEPCPSGTY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
LKEPCPSGTY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
LKEPCPSGTY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
LLACLCKHKK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
LLACLCKHKK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
LLACLCKHKK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
LLACLCKHKK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
LLALQQLEV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.8
LLALQQLEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
LLALQQLEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/fluorescence,dissociation constant KD,0.3
LLALQQLEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LLALQQLEV,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.3
LLALQQLEV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
LLALQQLEV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
LLALQQLEV,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4.5
LLALQQLEV,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
LLALQQLEV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
LLALQQLEV,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
LLALQQLEV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
LLALQQLEV,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,27
LLALQQLEV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LLALQQLEV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
LLALQQLEV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
LLALQQLEV,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
LLALQQLEV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
LLALQQLEV,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4
LLALQQLEV,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
LLALQQLEV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
LLALQQLEV,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,42
LLDDFVEII,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
LLDDFVEII,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
LLDDFVEII,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),5.5
LLFLAFVVFL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
LLFLAFVVFL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LLFLAFVVFL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.7
LLFLAFVVFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
LLFLAFVVFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
LLFLAFVVFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
LLFLAFVVFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LLFLMSFTI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
LLFLMSFTI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
LLFLMSFTI,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),9.5
LLFLVLIML,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
LLFLVLIML,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
LLFLVLIML,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
LLFLVLIML,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LLFLVLIML,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
LLFLVLIML,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
LLFLVLIMLI,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
LLFLVLIMLI,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
LLFLVLIMLI,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
LLFLVLIMLI,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
LLFLVLIMLI,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),3.5
LLFLVLIMLI,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
LLFNKVTLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
LLFNKVTLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LLFNKVTLA,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.3
LLFNKVTLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
LLFNKVTLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
LLFNKVTLA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
LLFNKVTLA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
LLFQLCTFT,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
LLFQLCTFT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
LLFQLCTFT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),16
LLLDDFVEI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
LLLDDFVEI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
LLLDDFVEI,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),2.5
LLLDRLNQL,HLA-A02:01,T Cell,Positive-High,ELISPOT,IFNg release,0.04
LLLDRLNQL,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.04
LLLDRLNQL,HLA-A02:01,T Cell,Positive,ELISA,IFNg release,0.04
LLLDRLNQL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.04
LLLDRLNQL,HLA-A02:01,MHC Binding,Positive-High,cellular MHC/direct/fluorescence,qualitative binding,0.04
LLLDRLNQL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.04
LLLDRLNQL,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.04
LLLEWLAEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.02
LLLEWLAEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
LLLEWLAEV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.04
LLLEWLAEV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
LLLEWLAEV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LLLEWLAEV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
LLLEWLAEVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
LLLEWLAEVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LLLEWLAEVV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
LLLEWLAEVV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
LLLEWLAEVV,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
LLLEWLAEVV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),14
LLLLDRLNQ,HLA-A02:01,MHC Binding,Positive,purified MHC,qualitative binding,5.5
LLLLDRLNQ,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,8.5
LLLLDRLNQ,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,45
LLLLDRLNQ,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,38
LLLLDRLNQL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,1.1
LLLLDRLNQL,HLA-A02:01,MHC Binding,Positive-High,cellular MHC/direct/fluorescence,qualitative binding,1.1
LLLLDRLNQL,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,1.1
LLLQYGSFC,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,4
LLLQYGSFC,HLA-A02:01,MHC Binding,Negative,cellular MHC/direct/fluorescence,qualitative binding,4
LLLSICLGSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
LLLSICLGSL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
LLLSICLGSL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),14
LLMPILTLT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
LLMPILTLT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
LLMPILTLT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
LLQYGSFCT,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,5.5
LLSAGIFGA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
LLSAGIFGA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
LLSAGIFGA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
LLTDDMIAA,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.3
LLVAAGMEA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
LLVAAGMEA,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
LLVAAGMEA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LLVAAGMEA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
LLVAAGMEA,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),20
LLVAAGMEA,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
LLVTLAILTA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
LLVTLAILTA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
LLVTLAILTA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
LLVTLAILTA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
LLVTLAILTA,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),20
LLVTLAILTA,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
LLYDANYFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.03
LLYDANYFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
LLYDANYFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LLYDANYFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
LLYDANYFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
LLYDANYFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
LMANLAPHL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
LMANLAPHL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
LMANLAPHL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
LMANLAPHL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
LMANLAPHL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
LMANLAPHL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
LMANLAPHLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
LMANLAPHLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
LMANLAPHLL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LMGHFSWWT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),14
LMGHFSWWT,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),30
LMGHFSWWT,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),65
LMGHFSWWTA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9.5
LMGHFSWWTA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),13
LMGHFSWWTA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),60
LMIERFVSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
LMIERFVSL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
LMIERFVSL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
LMLKATLLCV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
LMLKATLLCV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
LMLKATLLCV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),44
LMSFTILCL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
LMSFTILCL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
LMSFTILCL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),12
LMSFTILCLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7.5
LMSFTILCLV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
LMSFTILCLV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),16
LMWFIISIV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
LMWFIISIV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
LMWFIISIV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),4
LMWLSYFVA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
LMWLSYFVA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
LMWLSYFVA,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),14
LMWLSYFVA,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
LMWLSYFVA,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),65
LMWLSYFVA,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),65
LMYKGLPWNV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
LMYKGLPWNV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
LMYKGLPWNV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),13
LPDDFMGCVL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LPDDFMGCVL,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
LPDDFMGCVL,HLA-B51:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
LPDDFMGCVL,HLA-B53:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
LPDDFMGCVL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
LPFHRWHTM,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LPFHRWHTM,HLA-B35:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
LPFHRWHTM,HLA-B51:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
LPFHRWHTM,HLA-B53:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
LPFHRWHTM,HLA-B54:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
LPFHRWHTMV,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
LPFHRWHTMV,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
LPFHRWHTMV,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LPFHRWHTMV,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LPFHRWHTMV,HLA-B54:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
LPFYSNVTGF,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
LPFYSNVTGF,HLA-B35:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
LPFYSNVTGF,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
LPFYSNVTGF,HLA-B53:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
LPFYSNVTGF,HLA-B54:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
LQFAYSNRNR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
LQFAYSNRNR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
LQFAYSNRNR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
LQFAYSNRNR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
LQIPFAMQM,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
LQIPFAMQM,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
LQIPFAMQM,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
LQIPFAMQM,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
LQIPFAMQM,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
LQIPFAMQM,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
LQIPFAMQM,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
LQIPFAMQM,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
LQIPFAMQM,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
LQIPFAMQM,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.3
LQIPFAMQM,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.3
LQIPFAMQM,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.3
LQIPFAMQM,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
LQIPFAMQM,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
LQIPFAMQM,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),13
LQIPFAMQM,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
LQIPFAMQM,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),11
LQIPFAMQM,HLA-C15:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.7
LQLGFSTGV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
LQLGFSTGV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
LQLGFSTGV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),17
LQLPQGTTL,HLA-A02:01,T Cell,Positive-Low,ELISPOT,IFNg release,2.5
LQLPQGTTL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,2.5
LQLPQGTTL,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,2.5
LQLPQGTTL,HLA-A02:01,MHC Binding,Negative,cellular MHC/direct/fluorescence,qualitative binding,2.5
LQLPQGTTL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,2.5
LQSLENVAY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.9
LQSLENVAY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
LQSLENVAY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
LQSLENVAY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
LQSLENVAY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),12
LQSLENVAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),37
LQSLENVAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
LQSLENVAY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
LQSLENVAY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
LQSLENVAY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,27
LQSLENVAY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
LQSLENVAY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
LQSLENVAY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
LQSLENVAY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
LQSLENVAY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
LQSLENVAY,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.07
LQSLENVAY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.07
LQSLENVAY,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.07
LQSLENVAY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
LQSLENVAY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
LQSLENVAY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
LSDDAVVCY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
LSDDAVVCY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
LSDDAVVCY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.02
LSDDAVVCY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
LSDDAVVCY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
LSDDAVVCY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
LSDDAVVCY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
LSDDAVVCY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
LSDDAVVCY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
LSDDAVVCY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
LSDDAVVCY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
LSDDAVVCY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,38
LSDDAVVCY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,1.2
LSDDAVVCY,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,1.3
LSDDAVVCY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
LSDDAVVCY,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.7
LSPRWYFYY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
LSPRWYFYY,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
LSPRWYFYY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
LSPRWYFYY,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
LSPRWYFYY,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
LSPRWYFYY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
LSPRWYFYY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LSPRWYFYY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
LSPRWYFYY,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
LSPRWYFYY,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),31
LTALRLCAY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
LTALRLCAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),55
LTALRLCAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),42
LTALRLCAY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LTALRLCAY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
LTALRLCAY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
LTDDMIAAY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
LTDDMIAAY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
LTDDMIAAY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
LTDDMIAAY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.01
LTDDMIAAY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
LTDDMIAAY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.4
LTDDMIAAY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.4
LTDDMIAAY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5
LTDDMIAAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),37
LTDDMIAAY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
LTDDMIAAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
LTDDMIAAY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.4
LTDDMIAAY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LTDDMIAAY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
LTDDMIAAY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LTDDMIAAY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
LTDDMIAAY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
LTDDMIAAY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
LTDDMIAAY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
LTDDMIAAY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
LTDDMIAAY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
LTDDMIAAY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
LTDDMIAAY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.9
LTDDMIAAY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.9
LTQDLFLPFY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
LTQDLFLPFY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
LTQDLFLPFY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
LTQDLFLPFY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
LTQDLFLPFY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
LTQDLFLPFY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
LVFLILCFT,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
LVFLILCFT,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),12
LVFLILCFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
LVFLILCFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
LVFLILCFT,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
LVFLILCFT,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),2.5
LVFLWLLWPV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
LVFLWLLWPV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
LVFLWLLWPV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
LVFLWLLWPV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
LVFLWLLWPV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
LVFLWLLWPV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
LVIGFLFLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
LVIGFLFLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
LVIGFLFLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
LVIGFLFLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
LVIGFLFLA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
LVIGFLFLA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
LVIGVAFLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
LVIGVAFLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
LVIGVAFLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
LVIGVAFLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
LVIGVAFLA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
LVIGVAFLA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LVIGVAFLAV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
LVIGVAFLAV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
LVIGVAFLAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
LVIGVAFLAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
LVIGVAFLAV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
LVIGVAFLAV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
LVLSVNPYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
LVLSVNPYV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
LVLSVNPYV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
LWLLWPVTL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
LWLLWPVTL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LWLLWPVTL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
LWLLWPVTL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),55
LWLLWPVTL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
LWLLWPVTL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),41
LWPVTLACF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
LWPVTLACF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
LWPVTLACF,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
LWPVTLACF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
LWPVTLACF,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
LWPVTLACF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
LYDANYFVCW,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
LYDANYFVCW,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
LYDANYFVCW,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
LYDANYFVCW,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),90
LYDANYFVCW,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
LYDANYFVCW,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),55
LYIIKLVFL,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
LYIIKLVFL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
LYIIKLVFL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
LYIIKLVFL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
LYIIKLVFL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
LYIIKLVFL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
LYIIKLVFLW,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
LYIIKLVFLW,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
LYIIKLVFLW,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
LYIIKLVFLW,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
LYIIKLVFLW,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
LYIIKLVFLW,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
LYLTQDLFL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
LYLTQDLFL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
LYLTQDLFL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
LYLTQDLFL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
LYLTQDLFL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
LYLTQDLFL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
LYLTQDLFL,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.15
LYLTQDLFL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),49
LYLTQDLFL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
LYLTQDLFL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
LYLTQDLFL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
LYLTQDLFL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,38
LYLTQDLFL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
LYLTQDLFL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
LYLYALIYF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
LYLYALIYF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
LYLYALIYF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
LYLYALIYF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
LYLYALIYF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LYLYALIYF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
LYLYALIYFL,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
LYLYALIYFL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
LYLYALIYFL,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LYLYALIYFL,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),70
LYLYALIYFL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
LYLYALIYFL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
LYMAISPKF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
LYMAISPKF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
LYMAISPKF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
LYMAISPKF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
LYMAISPKF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
LYMAISPKF,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
LYNSTFFSTF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
LYNSTFFSTF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
LYNSTFFSTF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
LYNSTFFSTF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
LYNSTFFSTF,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
LYNSTFFSTF,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
MEAQFLYLY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
MEAQFLYLY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.9
MEAQFLYLY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
MEAQFLYLY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
MEAQFLYLY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
MEAQFLYLY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
MEAQFLYLY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
MEAQFLYLY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
MEAQFLYLY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
MEAQFLYLY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
MEAQFLYLY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
MEAQFLYLY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,1.6
MEAQFLYLY,HLA-B18:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
MEAQFLYLY,HLA-B40:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,1.4
MEAQFLYLY,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
MEAQFLYLY,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
MEAQFLYLY,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
MEAQFLYLY,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
MEAQFLYLY,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
MEAQFLYLY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
MEAQFLYLYA,HLA-B18:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
MEAQFLYLYA,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
MEAQFLYLYA,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
MEAQFLYLYA,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
MEAQFLYLYA,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
MEAQFLYLYA,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
MEVQSLAMST,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
MEVQSLAMST,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
MEVQSLAMST,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
MEVQSLAMST,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
MEVQSLAMST,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
MEVQSLAMST,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
MEVTPSGTW,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,39
MEVTPSGTW,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
MEVTPSGTW,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,50
MEVTPSGTW,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
MEVTPSGTW,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
MEVTPSGTW,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
MEVTPSGTW,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,0.7
MEVTPSGTW,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
MEVTPSGTW,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
MEVTPSGTWL,HLA-B40:01,T Cell,Positive,multimer/tetramer,qualitative binding,0.06
MEVTPSGTWL,HLA-B40:01,T Cell,Positive,ICS,IFNg release,0.06
MEVTPSGTWL,HLA-B40:01,T Cell,Positive,ELISPOT,IFNg release,0.06
MEVTPSGTWL,HLA-B40:01,MHC Binding,Positive,purified MHC,qualitative binding,0.06
MEVTPSGTWLT,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,5.5
MIAAYTAAL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,4
MIAAYTAAL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,4
MIAAYTAAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
MIAAYTAAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
MIAAYTAAL,HLA-A02:01,T Cell,Negative,51 chromium,cytotoxicity,4
MIAAYTAAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
MIAAYTAAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
MIAAYTAAL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
MIAAYTAAL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
MIFDNAFNC,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,5
MIFDNAFNC,HLA-A02:01,MHC Binding,Negative,cellular MHC/direct/fluorescence,qualitative binding,5
MKELSPRWY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
MKELSPRWY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),80
MKELSPRWY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),50
MKELSPRWY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),37
MKELSPRWY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
MKELSPRWY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
MLFTKFFYL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
MLFTKFFYL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
MLFTKFFYL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
MLIIFWFSL,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
MLIIFWFSL,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
MLIIFWFSL,HLA-A02:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
MLIIFWFSL,HLA-A02:03,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1.3
MLIIFWFSL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
MLIIFWFSL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1
MLLQFAYSNR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
MLLQFAYSNR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
MLLQFAYSNR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
MLLQFAYSNR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
MLLTFLTSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
MLLTFLTSL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
MLLTFLTSL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
MLLTFLTSLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
MLLTFLTSLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
MLLTFLTSLL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),12
MLPPCYNFLK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
MLPPCYNFLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
MLPPCYNFLK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
MLPPCYNFLK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
MLWCKDGHV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
MLWCKDGHV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
MLWCKDGHV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),10
MMISAGFSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2
MMISAGFSL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
MMISAGFSL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
MPASWVMRI,HLA-B07:02,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,1.4
MPASWVMRI,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,1.9
MQVFFGYFA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),16
MQVFFGYFA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),28
MQVFFGYFA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7.5
MSLYMAISPK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
MSLYMAISPK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
MSLYMAISPK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
MSLYMAISPK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
MTNRQFHQK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,1.8
MTNRQFHQK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.3
MTSCCSCLK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
MTSCCSCLK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
MTSCCSCLK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
MTSCCSCLK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
MVMCGGSLYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
MVMCGGSLYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
MVMCGGSLYV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
MWLSYFVASF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
MWLSYFVASF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
MWLSYFVASF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
MWLSYFVASF,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
MWLSYFVASF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
MWLSYFVASF,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
MWSFNPETNI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
MWSFNPETNI,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
MWSFNPETNI,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
MWSFNPETNI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),60
MWSFNPETNI,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),31
MWSFNPETNI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),70
NAFNCTFEY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
NAFNCTFEY,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
NAFNCTFEY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
NAFNCTFEY,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
NATFFIFNK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
NATFFIFNK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
NATFFIFNK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
NATFFIFNK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
NELTLIDFYL,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
NELTLIDFYL,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
NELTLIDFYL,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
NELTLIDFYL,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
NELTLIDFYL,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
NELTLIDFYL,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
NFKHLREFVF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),65
NFKHLREFVF,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
NFKHLREFVF,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
NFKHLREFVF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
NFKHLREFVF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
NFKHLREFVF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
NFLKEQHCQK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
NFLKEQHCQK,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
NFLKEQHCQK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
NFLKEQHCQK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
NIDATSTGNY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
NIDATSTGNY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),60
NIDATSTGNY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),49
NIDATSTGNY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
NIDATSTGNY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
NIDATSTGNY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
NKDGFLYVY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
NKDGFLYVY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
NKDGFLYVY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
NKDGFLYVY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
NKDGFLYVY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
NKDGFLYVY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
NLAPHLLLI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
NLAPHLLLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
NLAPHLLLI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
NLAPHLLLIV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
NLAPHLLLIV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
NLAPHLLLIV,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
NLCTHSFRK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
NLCTHSFRK,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
NLCTHSFRK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
NLCTHSFRK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
NLLDSYFVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
NLLDSYFVV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
NLLDSYFVV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
NLLLLFVTI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
NLLLLFVTI,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
NLLLLFVTI,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
NLLLLFVTI,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
NLLLLFVTI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
NLLLLFVTI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
NLNESLIDL,HLA-A02:01,T Cell,Positive,51 chromium,cytotoxicity,0.15
NLNESLIDL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.15
NLNESLIDL,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.15
NLNESLIDL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.15
NLNESLIDL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.15
NLVIGFLFL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
NLVIGFLFL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
NLVIGFLFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
NLVIGFLFL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
NLVIGFLFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
NLVIGFLFL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
NLVIGFLFLA,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
NLVIGFLFLA,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
NLVIGFLFLA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
NLVIGFLFLA,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7.5
NLVIGFLFLA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),11
NLVIGFLFLA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
NLWNTFTRL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
NLWNTFTRL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
NLWNTFTRL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
NMLRIMASL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
NMLRIMASL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
NMLRIMASL,HLA-A23:01,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1
NMLRIMASL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
NQATTKTTF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
NQATTKTTF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
NQATTKTTF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
NQATTKTTF,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),23
NQATTKTTF,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
NQATTKTTF,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
NQATTKTTF,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
NQATTKTTF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
NQATTKTTF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),8
NQATTKTTF,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4.5
NQATTKTTF,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.08
NQATTKTTF,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.08
NQATTKTTF,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.08
NQATTKTTF,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
NQATTKTTF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),9
NQATTKTTF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
NQATTKTTF,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
NQATTKTTF,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5
NQLESKVSGK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
NQLESKVSGK,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
NQLESKVSGK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
NQLESKVSGK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
NSGPDDQIGY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
NSGPDDQIGY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
NSGPDDQIGY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),35
NSGPDDQIGY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
NSGPDDQIGY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
NSGPDDQIGY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
NVLAWLYAA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
NVLAWLYAA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
NVLAWLYAA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
NVSLVKPTVY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
NVSLVKPTVY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),36
NVSLVKPTVY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
NVSLVKPTVY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
NVSLVKPTVY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
NVSLVKPTVY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
NVYADSFVVK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
NVYADSFVVK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
NVYADSFVVK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
NVYADSFVVK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
NYMPYVFTL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
NYMPYVFTL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
NYMPYVFTL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/fluorescence,dissociation constant KD,0.01
NYMPYVFTL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
NYMPYVFTL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
NYMPYVFTL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
NYMPYVFTL,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
NYMPYVFTL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
NYMPYVFTL,HLA-C07:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
NYNYKYRYL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
NYNYKYRYL,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
NYNYKYRYL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
NYNYKYRYL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
NYNYKYRYL,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
NYNYKYRYL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
NYTQHTSSM,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
NYTQHTSSM,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
NYTQHTSSM,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
NYTQHTSSM,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
NYTQHTSSM,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
NYTQHTSSM,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
PPALNCYWPL,HLA-B07:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
PPALNCYWPL,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
PPALNCYWPL,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
PPALNCYWPL,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
PPALNCYWPL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
PQIQLTITR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
PQIQLTITR,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
PQIQLTITR,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
PQIQLTITR,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
PSGTWLTYH,HLA-B40:01,MHC Binding,Positive,purified MHC,qualitative binding,65
PVDEYITTY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.04
PVDEYITTY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.04
PVDEYITTY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.04
PVDEYITTY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
PVDEYITTY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
PVDEYITTY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.3
PVDEYITTY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.9
PVDEYITTY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
PVDEYITTY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
PVDEYITTY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
PVDEYITTY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.08
PVDEYITTY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
PVDEYITTY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
PVDEYITTY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
PVDEYITTY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
PVDEYITTY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
PVDEYITTY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
PVDEYITTY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.17
PVDEYITTY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
PVDEYITTY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
PVDEYITTY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.2
PYNSVTDTI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
PYNSVTDTI,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
PYNSVTDTI,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
PYNSVTDTI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),41
PYNSVTDTI,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
PYNSVTDTI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
PYRVVVLSF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
PYRVVVLSF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
PYRVVVLSF,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
PYRVVVLSF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
PYRVVVLSF,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
PYRVVVLSF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
QEEVQQELY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
QEEVQQELY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),36
QEEVQQELY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
QEEVQQELY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),39
QEEVQQELY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
QEEVQQELY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
QEIQLLAAV,HLA-B18:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
QEIQLLAAV,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
QEIQLLAAV,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
QEIQLLAAV,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
QEIQLLAAV,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
QEIQLLAAV,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
QEIQLLAAVG,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
QEIQLLAAVG,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
QEIQLLAAVG,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
QEIQLLAAVG,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
QEIQLLAAVG,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
QEIQLLAAVG,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
QELGKYEQYI,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
QELGKYEQYI,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
QELGKYEQYI,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
QELGKYEQYI,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
QELGKYEQYI,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
QELGKYEQYI,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
QELLIQQWI,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
QELLIQQWI,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
QELLIQQWI,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
QELLIQQWI,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
QELLIQQWI,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
QELLIQQWI,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
QELYSPLFL,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
QELYSPLFL,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
QELYSPLFL,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
QELYSPLFL,HLA-B44:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
QELYSPLFL,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
QELYSPLFL,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
QELYSPLFLI,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
QELYSPLFLI,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
QELYSPLFLI,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
QELYSPLFLI,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
QELYSPLFLI,HLA-B44:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
QELYSPLFLI,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
QESLTTTSTA,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
QESLTTTSTA,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
QESLTTTSTA,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
QESLTTTSTA,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
QESLTTTSTA,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
QESLTTTSTA,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
QFKDNVILL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
QFKDNVILL,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
QFKDNVILL,HLA-A24:02,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.3
QFKDNVILL,HLA-A24:02,MHC Binding,Positive,x-ray crystallography,3D structure,0.3
QFKDNVILL,HLA-A24:02,T Cell,Positive,multimer/tetramer,qualitative binding,0.3
QFKDNVILL,HLA-A24:02,T Cell,Positive,CFSE,proliferation,0.3
QFKDNVILL,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
QFKDNVILL,HLA-A24:02,T Cell,Positive,ELISPOT,IFNg release,0.3
QFKDNVILL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
QFKDNVILL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
QFKDNVILL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
QFLYLYALI,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
QFLYLYALI,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
QFLYLYALI,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
QFLYLYALI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
QFLYLYALI,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
QFLYLYALI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
QLFKPLTKK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
QLFKPLTKK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
QLFKPLTKK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
QLFKPLTKK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.04
QLFKPLTKK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
QLFKPLTKK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.4
QLFKPLTKK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
QLFKPLTKK,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
QLFKPLTKK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
QLFKPLTKK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.9
QLFKPLTKK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
QLFKPLTKK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
QLFKPLTKK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
QLFKPLTKK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
QLFKPLTKK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
QLFKPLTKK,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
QLFKPLTKK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
QLFKPLTKK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
QLMCQPILL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
QLMCQPILL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
QLMCQPILL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
QLMCQPILLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
QLMCQPILLL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
QLMCQPILLL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),12
QLPQGTTLPK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
QLPQGTTLPK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
QLPQGTTLPK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),47
QLPQGTTLPK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
QLQNSMSGA,HLA-A02:01,MHC Binding,Negative,cellular MHC/direct/fluorescence,qualitative binding,3.5
QMYKTPTLKY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
QMYKTPTLKY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
QMYKTPTLKY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
QMYKTPTLKY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
QMYKTPTLKY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
QMYKTPTLKY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
QNSADPKVY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
QNSADPKVY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),47
QNSADPKVY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
QNSADPKVY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
QNSADPKVY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
QNSADPKVY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
QPTVTLLPA,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
QPTVTLLPA,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
QPTVTLLPA,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
QPTVTLLPA,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
QPTVTLLPA,HLA-B54:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
QPYRVVVLSF,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
QPYRVVVLSF,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
QPYRVVVLSF,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
QPYRVVVLSF,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
QPYRVVVLSF,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
QQQGQTVTK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
QQQGQTVTK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
QQQGQTVTK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
QQQGQTVTK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
QQQGQTVTKK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
QQQGQTVTKK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
QQQGQTVTKK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
QQQGQTVTKK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
QQQQGQTVTK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
QQQQGQTVTK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
QQQQGQTVTK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
QQQQGQTVTK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
QQWIQFMMSR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
QQWIQFMMSR,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
QQWIQFMMSR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
QQWIQFMMSR,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
QSADASTFLK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
QSADASTFLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
QSADASTFLK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
QSADASTFLK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
QSLCFLLTQK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
QSLCFLLTQK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
QSLCFLLTQK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
QSLCFLLTQK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
QWNLVIGFLF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
QWNLVIGFLF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
QWNLVIGFLF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
QWNLVIGFLF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
QWNLVIGFLF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
QWNLVIGFLF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
QYGSFCTQL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
QYGSFCTQL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
QYGSFCTQL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
QYGSFCTQL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
QYGSFCTQL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
QYGSFCTQL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),28
QYIKWPWYVW,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),70
QYIKWPWYVW,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
QYIKWPWYVW,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
QYIKWPWYVW,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
QYIKWPWYVW,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
QYIKWPWYVW,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
REFVFKNKDG,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
REFVFKNKDG,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
REFVFKNKDG,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
REFVFKNKDG,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
REFVFKNKDG,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
REFVFKNKDG,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
REGVFVFNG,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
REGVFVFNG,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
REGVFVFNG,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
REGVFVFNG,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
REGVFVFNG,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
REGVFVFNG,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
REGVFVFNGT,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
REGVFVFNGT,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
REGVFVFNGT,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
REGVFVFNGT,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
REGVFVFNGT,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
REGVFVFNGT,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
REVSTAAVT,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
REVSTAAVT,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
REVSTAAVT,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
REVSTAAVT,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
REVSTAAVT,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
REVSTAAVT,HLA-B45:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
RFFTLGSIT,HLA-B58:01,MHC Binding,Positive,purified MHC,qualitative binding,16
RFFTLGSITA,HLA-B58:01,MHC Binding,Positive,purified MHC,qualitative binding,19
RFFTLGSITAQ,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,55
RFFTLGSITAQPVKI,HLA-B58:01,T Cell,Positive,ELISPOT,IFNg release,60
RFFTLGSITAQPVKI,HLA-B58:01,MHC Binding,Positive,purified MHC,qualitative binding,60
RFLYIIKLVF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),55
RFLYIIKLVF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
RFLYIIKLVF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
RFLYIIKLVF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
RFLYIIKLVF,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
RFLYIIKLVF,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
RFQPFQQFGR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
RFQPFQQFGR,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
RFQPFQQFGR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
RFQPFQQFGR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
RHYSASFKK,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
RHYSASFKK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
RHYSASFKK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.3
RHYSASFKK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.3
RHYSASFKK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
RHYSASFKK,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
RHYSASFKK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
RHYSASFKK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
RHYSASFKK,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,75
RHYSASFKK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
RHYSASFKK,HLA-B27:05,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.8
RHYSASFKK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
RHYSASFKK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
RILGAGCFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
RILGAGCFV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
RILGAGCFV,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),11
RLCAYCCNI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
RLCAYCCNI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
RLCAYCCNI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
RLCAYCCNI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
RLCAYCCNI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),39
RLCAYCCNI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),39
RLDKVEAEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
RLDKVEAEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.07
RLDKVEAEV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
RLDKVEAEV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
RLDKVEAEV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
RLDKVEAEV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
RLLACLCKHK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
RLLACLCKHK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
RLLACLCKHK,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
RLLACLCKHK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),55
RLNEVAKNL,HLA-A02:01,T Cell,Positive,multimer/tetramer,qualitative binding,0.25
RLNEVAKNL,HLA-A02:01,T Cell,Positive,51 chromium,cytotoxicity,0.25
RLNEVAKNL,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.25
RLNEVAKNL,HLA-A02:01,T Cell,Positive,ICS,IFNg release,0.25
RLNEVAKNL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.25
RLNQLESKV,HLA-A02:01,MHC Binding,Positive-Intermediate,cellular MHC/direct/fluorescence,qualitative binding,0.5
RLNQLESKV,HLA-A02:01,T Cell,Positive-Intermediate,ELISPOT,IFNg release,0.5
RLNQLESKV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.5
RLNQLESKV,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.5
RLNQLESKV,HLA-A02:01,T Cell,Positive,ELISA,IFNg release,0.5
RLNQLESKV,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.5
RLNQLESKV,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.5
RLNQLESKV,HLA-A02:01,MHC Binding,Positive,cellular MHC/competitive/fluorescence,qualitative binding,0.5
RLQSLQTYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
RLQSLQTYV,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.17
RLQSLQTYV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.17
RLQSLQTYV,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.17
RLQSLQTYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
RLQSLQTYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
RLQSLQTYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
RLQSLQTYV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
RLQSLQTYV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
RLVDAMVYT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
RLVDAMVYT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
RLVDAMVYT,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),11
RLYYDSMSY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
RLYYDSMSY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
RLYYDSMSY,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.07
RLYYDSMSY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.07
RLYYDSMSY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,4
RLYYDSMSY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4
RLYYDSMSY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
RLYYDSMSY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
RLYYDSMSY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.02
RLYYDSMSY,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.02
RLYYDSMSY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
RLYYDSMSY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1
RPKQRRPQGL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
RPKQRRPQGL,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
RPKQRRPQGL,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
RPKQRRPQGL,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
RPKQRRPQGL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
RPLMESELV,HLA-B07:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
RPLMESELV,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
RPLMESELV,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
RPLMESELV,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
RPLMESELV,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
RPLMESELVI,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
RPLMESELVI,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
RPLMESELVI,HLA-B51:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
RPLMESELVI,HLA-B53:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
RPLMESELVI,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
RQLFKPLTK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
RQLFKPLTK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
RQLFKPLTK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
RQLFKPLTK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
RQLFKPLTKK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
RQLFKPLTKK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
RQLFKPLTKK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
RQLFKPLTKK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
RQLLFVVEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
RQLLFVVEV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
RQLLFVVEV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9
RRGPEQTQG,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,49
RRGPEQTQG,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
RRGPEQTQG,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
RRGPEQTQG,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
RRGPEQTQG,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,48
RRGPEQTQG,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
RRGPEQTQG,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
RRGPEQTQG,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,75
RRGPEQTQG,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
RRGPEQTQG,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
RRGPEQTQG,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
RRGPEQTQG,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
RVDFCGKGY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.25
RVDFCGKGY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.25
RVDFCGKGY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
RVDFCGKGY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
RVDFCGKGY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
RVDFCGKGY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3
RVDFCGKGY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4.5
RVDFCGKGY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),42
RVDFCGKGY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),48
RVDFCGKGY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,48
RVDFCGKGY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
RVDFCGKGY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
RVDFCGKGY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
RVDFCGKGY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
RVDFCGKGY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
RVDFCGKGY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
RVDFCGKGY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,47
RVDFCGKGY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.4
RVDFCGKGY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
RVDFCGKGY,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4.5
RVDFCGKGY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
RVDFCGKGY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.4
RVFNNYMPY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
RVFNNYMPY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
RVFNNYMPY,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.02
RVFNNYMPY,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.02
RVFNNYMPY,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
RVFNNYMPY,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
RVFNNYMPY,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
RVFNNYMPY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.5
RVFNNYMPY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,27
RVFNNYMPY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.25
RVFNNYMPY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.25
RVFNNYMPY,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3.5
RVFNNYMPY,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
RVFNNYMPY,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
RVFNNYMPY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
RVFNNYMPY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
RVFNNYMPY,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.12
RVFNNYMPY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.12
RVFNNYMPY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.12
RVFNNYMPY,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4
RVFNNYMPY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
RVFNNYMPY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.9
RVFNNYMPY,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.9
RVPRNLTLSK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
RVPRNLTLSK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
RVPRNLTLSK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
RVPRNLTLSK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
RYNTRGNTY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
RYNTRGNTY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
RYNTRGNTY,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
RYNTRGNTY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
RYNTRGNTY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
RYNTRGNTY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
RYRIGNYKL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
RYRIGNYKL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
RYRIGNYKL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
RYRIGNYKL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
RYRIGNYKL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
RYRIGNYKL,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SAAAYFVGY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SAAAYFVGY,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SAAAYFVGY,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SAAAYFVGY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
SAAAYFVGY,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
SAAAYFVGY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SAAAYFVGY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
SAAAYFVGY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SAAAYFVGY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
SAAAYFVGY,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
SADASTFLK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
SADASTFLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
SADASTFLK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
SADASTFLK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SAFFGMSRIG,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),44
SAFFGMSRIG,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),41
SAFFGMSRIG,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
SAFFGMSRIG,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
SAFFGMSRIG,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),40
SAFFGMSRIG,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
SASAFFGMSR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
SASAFFGMSR,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
SASAFFGMSR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
SASAFFGMSR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
SEETGTLIV,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
SEETGTLIV,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
SEETGTLIV,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
SEETGTLIV,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SEETGTLIV,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SEETGTLIV,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
SEGVPDLLV,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SEGVPDLLV,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
SEGVPDLLV,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SEGVPDLLV,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
SEGVPDLLV,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
SEGVPDLLV,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SELVIGAVI,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SELVIGAVI,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
SELVIGAVI,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
SELVIGAVI,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
SELVIGAVI,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
SELVIGAVI,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
SELVIGAVII,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
SELVIGAVII,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
SELVIGAVII,HLA-B40:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SELVIGAVII,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
SELVIGAVII,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
SELVIGAVII,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
SEPVLKGVKL,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
SEPVLKGVKL,HLA-B40:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
SEPVLKGVKL,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SEPVLKGVKL,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SEPVLKGVKL,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SEPVLKGVKL,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
SEVAVLYQDV,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
SEVAVLYQDV,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
SEVAVLYQDV,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SEVAVLYQDV,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
SEVAVLYQDV,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
SEVAVLYQDV,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
SFIEDLLFNK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
SFIEDLLFNK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
SFIEDLLFNK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
SFIEDLLFNK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
SFNHVLKRK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SFNHVLKRK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
SFNHVLKRK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SFNHVLKRK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
SFNPETNIL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
SFNPETNIL,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
SFNPETNIL,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
SFNPETNIL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
SFNPETNIL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
SFNPETNIL,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
SITAQPVKI,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,6
SITAQPVKI,HLA-B58:01,T Cell,Positive,multimer/tetramer,qualitative binding,6
SITAQPVKI,HLA-B58:01,T Cell,Positive,ICS,IFNg release,6
SIVAYTMSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SIVAYTMSL,HLA-A02:01,T Cell,Positive,51 chromium,cytotoxicity,3
SIVAYTMSL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,3
SIVAYTMSL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,3
SIVAYTMSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
SIVAYTMSL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
SIVAYTMSL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
SIVAYTMSL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
SIVAYTMSL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
SLAIDAYPL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.6
SLCFLLTQK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
SLCFLLTQK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
SLCFLLTQK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
SLCFLLTQK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
SLCSCICTV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
SLCSCICTV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
SLCSCICTV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
SLCSCICTV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
SLCSCICTV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
SLCSCICTV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
SLIDLQELGK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
SLIDLQELGK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SLIDLQELGK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
SLIDLQELGK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
SLLKTHRMCK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SLLKTHRMCK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
SLLKTHRMCK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
SLLKTHRMCK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
SLLRSTSQK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
SLLRSTSQK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
SLLRSTSQK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SLLRSTSQK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SLLSVLLSM,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
SLLSVLLSM,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
SLLSVLLSM,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),10
SLPSYAAYA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
SLPSYAAYA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
SLPSYAAYA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),11
SLTSLLKTHR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
SLTSLLKTHR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
SLTSLLKTHR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
SLTSLLKTHR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SLVKPTVYV,HLA-A02:01,MHC Binding,Positive-High,cellular MHC/direct/fluorescence,qualitative binding,0.1
SLVKPTVYV,HLA-A02:01,MHC Binding,Positive,purified MHC,qualitative binding,0.1
SLVKPTVYV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
SLVKPTVYV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.1
SLVKPTVYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SLVKPTVYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
SLVKPTVYV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
SLVKPTVYV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
SLYMAISPK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
SLYMAISPK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SLYMAISPK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
SLYMAISPK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SMWALVISV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
SMWALVISV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
SMWALVISV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
SMWSFNPET,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
SMWSFNPET,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
SMWSFNPET,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
SMWSFNPET,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
SMWSFNPET,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),19
SMWSFNPET,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
SPKFTTSLSL,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
SPKFTTSLSL,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SPKFTTSLSL,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
SPKFTTSLSL,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
SPKFTTSLSL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
SPLFLIVAA,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SPLFLIVAA,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
SPLFLIVAA,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
SPLFLIVAA,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
SPLFLIVAA,HLA-B54:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
SPLFLIVAAL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
SPLFLIVAAL,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SPLFLIVAAL,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
SPLFLIVAAL,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
SPLFLIVAAL,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SPRWYFYYL,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
SPRWYFYYL,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SPRWYFYYL,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
SPRWYFYYL,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SPRWYFYYL,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SQASSRSSSR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
SQASSRSSSR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SQASSRSSSR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
SQASSRSSSR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
SQILPDPLK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
SQILPDPLK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SQILPDPLK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
SQILPDPLK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
SQIQLSLLK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
SQIQLSLLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
SQIQLSLLK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
SQIQLSLLK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
SQLSLSMAR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SQLSLSMAR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SQLSLSMAR,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SQLSLSMAR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SQLSLSMAR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
SQLSLSMAR,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
SQLSLSMAR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SQLSLSMAR,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SQLSLSMARR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
SQLSLSMARR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
SQLSLSMARR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SQLSLSMARR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
SQLSLSMARR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SQLSLSMARR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SQMETDFLEL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
SQMETDFLEL,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2
SQMETDFLEL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),9
SQNPLAELK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
SQNPLAELK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
SQNPLAELK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
SQNPLAELK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
SSIVRQLFK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
SSIVRQLFK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
SSIVRQLFK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
SSIVRQLFK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
SSLPSYAAY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.6
SSLPSYAAY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SSLPSYAAY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.6
SSLPSYAAY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
SSLPSYAAY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.3
SSLPSYAAY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.9
SSLPSYAAY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,0.9
SSLPSYAAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
SSLPSYAAY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
SSLPSYAAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
SSLPSYAAY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
SSLPSYAAY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.8
SSLPSYAAY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SSLPSYAAY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
SSLPSYAAY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
SSLPSYAAY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
SSLPSYAAY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
SSLPSYAAY,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.5
SSLPSYAAY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.5
SSLPSYAAY,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
SSLPSYAAY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
SSLPSYAAY,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,2.5
SSLPSYAAY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
SSLPSYAAY,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.7
SSLPSYAAY,HLA-B58:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.7
SSNVANYQK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.17
SSNVANYQK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
SSNVANYQK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
SSSLTSLLK,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.9
SSSLTSLLK,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,44
SSSLTSLLK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.7
SSSLTSLLK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SSSLTSLLK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.7
SSSLTSLLK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.12
SSSLTSLLK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
SSSLTSLLK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.12
SSSLTSLLK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
SSSLTSLLK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
SSSLTSLLK,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
SSSLTSLLK,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
SSSLTSLLK,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
SSSLTSLLK,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
STAAVTMSMK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
STAAVTMSMK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
STAAVTMSMK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),17
STAAVTMSMK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
STAWLCALGK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
STAWLCALGK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
STAWLCALGK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
STAWLCALGK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
STDDCFANK,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,0.25
STDDCFANK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.03
STGNYNYKY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
STGNYNYKY,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
STGNYNYKY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
STGNYNYKY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
STGNYNYKY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
STGNYNYKY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
STGNYNYKY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
STGNYNYKY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
STGNYNYKY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
STGNYNYKY,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
STGNYNYKYR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
STGNYNYKYR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
STGNYNYKYR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
STGNYNYKYR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
STNLCTHSFR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
STNLCTHSFR,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
STNLCTHSFR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
STNLCTHSFR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
STPIVVQMTK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
STPIVVQMTK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
STPIVVQMTK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
STPIVVQMTK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
STPIVVQMTK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
STPKLKEDY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
STPKLKEDY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
STPKLKEDY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
STPKLKEDY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
STPKLKEDY,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
STPKLKEDY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
STQWSLFFFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),9.5
STQWSLFFFV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),23
STQWSLFFFV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
STRHPSKLR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
STRHPSKLR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
STRHPSKLR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
STRHPSKLR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
STSQKSIVAY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
STSQKSIVAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
STSQKSIVAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),34
STSQKSIVAY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
STSQKSIVAY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
STSQKSIVAY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SVKSFEIDK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
SVKSFEIDK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
SVKSFEIDK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SVKSFEIDK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
SVLLFLAFV,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.9
SVLLFLAFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
SVLLFLAFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
SVLLFLAFV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
SVLLFLAFV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
SVLLFLAFV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
SVLLFLAFV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
SVLLFLAFVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
SVLLFLAFVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
SVLLFLAFVV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
SVLLFLAFVV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),21
SVLLFLAFVV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SVLLFLAFVV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
SVLNDILSR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
SVLNDILSR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
SVLNDILSR,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
SVLNDILSR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
SVSPKLFIR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SVSPKLFIR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
SVSPKLFIR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
SVSPKLFIR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
SVYAWERKK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
SVYAWERKK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
SVYAWERKK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
SVYAWERKK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SWFITQRNF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
SWFITQRNF,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SWFITQRNF,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SWFITQRNF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SWFITQRNF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
SWFITQRNF,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SWFITQRNFF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
SWFITQRNFF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
SWFITQRNFF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
SWFITQRNFF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
SWFITQRNFF,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
SWFITQRNFF,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
SYCNGVREL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
SYCNGVREL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
SYCNGVREL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
SYCNGVREL,HLA-A24:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.5
SYCNGVREL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
SYCNGVREL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
SYCNGVREL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
SYCNGVREL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
SYCNGVREL,HLA-C04:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.15
SYCNGVREL,HLA-C06:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.01
SYFVASFRLF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
SYFVASFRLF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
SYFVASFRLF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
SYFVASFRLF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
SYFVASFRLF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
SYFVASFRLF,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
SYFVASFRLF,HLA-B18:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
SYFVASFRLF,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
SYFVASFRLF,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
SYFVASFRLF,HLA-B44:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
SYFVASFRLF,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
SYFVASFRLF,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
TAFQHQNSKK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
TAFQHQNSKK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TAFQHQNSKK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
TAFQHQNSKK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
TALALLLLD,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,17
TALALLLLD,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,18
TALALLLLD,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,25
TALALLLLD,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,30
TALALLLLDR,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,45
TALALLLLDR,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,49
TALALLLLDR,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,49
TALALLLLDR,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,80
TALALLLLDRL,HLA-A02:01,MHC Binding,Negative,purified MHC,qualitative binding,29
TALALLLLDRL,HLA-A02:07,MHC Binding,Negative,purified MHC,qualitative binding,30
TALALLLLDRL,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,17
TALALLLLDRL,HLA-B46:01,MHC Binding,Negative,purified MHC,qualitative binding,90
TEKSNVVRG,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
TEKSNVVRG,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
TEKSNVVRG,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
TEKSNVVRG,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
TEKSNVVRG,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TEKSNVVRG,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
TEVMPVSMA,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TEVMPVSMA,HLA-B40:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
TEVMPVSMA,HLA-B40:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
TEVMPVSMA,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
TEVMPVSMA,HLA-B44:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
TEVMPVSMA,HLA-B45:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
TFFIFNKLVK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
TFFIFNKLVK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TFFIFNKLVK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
TFFIFNKLVK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
TFFSTFKCY,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
TFFSTFKCY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
TFFSTFKCY,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
TFFSTFKCY,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
TFGNPVIPFK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
TFGNPVIPFK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TFGNPVIPFK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
TFGNPVIPFK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
TIYSHLLLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
TIYSHLLLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
TIYSHLLLV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
TIYSHLLLV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
TIYSHLLLV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
TIYSHLLLV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
TLACFVLAA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
TLACFVLAA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
TLACFVLAA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
TLACFVLAA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.07
TLACFVLAA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
TLACFVLAA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
TLACFVLAAV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
TLACFVLAAV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
TLACFVLAAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.04
TLACFVLAAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
TLACFVLAAV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
TLACFVLAAV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
TLADAGFMK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
TLADAGFMK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
TLADAGFMK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TLADAGFMK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
TLAILTALR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
TLAILTALR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TLAILTALR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
TLAILTALR,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
TLDAANHSI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
TLDAANHSI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
TLDAANHSI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
TLGSITAQP,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,22
TLGSITAQPV,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,65
TLGSITAQPVK,HLA-B58:01,MHC Binding,Negative,purified MHC,qualitative binding,70
TLGVYDYLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
TLGVYDYLV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
TLGVYDYLV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
TLIDFYLCFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
TLIDFYLCFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
TLIDFYLCFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
TLIDFYLCFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
TLIDFYLCFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
TLIDFYLCFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
TLIGDCATV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
TLIGDCATV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.02
TLIGDCATV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
TLLCVLAAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
TLLCVLAAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
TLLCVLAAL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
TLLCVLAALV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
TLLCVLAALV,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
TLLCVLAALV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
TLMNVITLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
TLMNVITLV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.03
TLMNVITLV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
TLNEDLLEI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
TLNEDLLEI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.03
TLNEDLLEI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
TLVPQEHYV,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
TLVPQEHYV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.04
TLVPQEHYV,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),20
TLVPQEHYV,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
TLVPQEHYV,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
TLVPQEHYV,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
TLVPQEHYV,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
TMADLVYAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
TMADLVYAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.1
TMADLVYAL,HLA-A23:01,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),0.9
TMADLVYAL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
TMNNKSQSV,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,1.3
TPRDLGACI,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
TPRDLGACI,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),19
TPRDLGACI,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
TPRDLGACI,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,41
TPRDLGACI,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),50
TPRDLGACI,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
TPRDLGACI,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
TPRDLGACI,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
TPRDLGACI,HLA-B07:02,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.5
TPRDLGACI,HLA-B07:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.5
TPRDLGACI,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.5
TPRDLGACI,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
TPRDLGACI,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
TPRDLGACI,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,26
TPRDLGACI,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,38
TPRDLGACI,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
TPRDLGACI,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
TPRDLGACI,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
TPRDLGACI,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
TPRDLGACI,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
TPRDLGACI,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,39
TPSGTWLTY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
TPSGTWLTY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
TPSGTWLTY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
TPSGTWLTY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
TPSGTWLTY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
TPSGTWLTY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
TPSGTWLTY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
TPSGTWLTY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
TPSGTWLTY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
TPSGTWLTY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
TPSGTWLTY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
TPSGTWLTY,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
TPSGTWLTY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
TPSGTWLTY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
TPSGTWLTY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.7
TPSGTWLTY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
TPSGTWLTY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.5
TPSGTWLTY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
TPSGTWLTY,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,16
TPSGTWLTY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
TPSGTWLTY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
TPSGTWLTYH,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,23
TQDLFLPFY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
TQDLFLPFY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.17
TQDLFLPFY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.17
TQDLFLPFY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
TQDLFLPFY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
TQDLFLPFY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),7.5
TQDLFLPFY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,7.5
TQDLFLPFY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
TQDLFLPFY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
TQDLFLPFY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
TQDLFLPFY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
TQDLFLPFY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
TQDLFLPFY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
TQDLFLPFY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
TQDLFLPFY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
TQDLFLPFY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
TQDLFLPFY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,55
TQDLFLPFY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.3
TQDLFLPFY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.3
TQDLFLPFY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
TQDLFLPFY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
TQDLFLPFY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
TQDLFLPFY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),20
TQNVLYENQK,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
TQNVLYENQK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
TQNVLYENQK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
TQNVLYENQK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
TQVLKTMSLY,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
TQVLKTMSLY,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
TQVLKTMSLY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),31
TQVLKTMSLY,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
TQWSLFFFV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
TQWSLFFFV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
TQWSLFFFV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
TSQKSIVAY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
TSQKSIVAY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
TSQKSIVAY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
TSQKSIVAY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
TSQKSIVAY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
TSQKSIVAY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
TSRTLSYYK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
TSRTLSYYK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
TSRTLSYYK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
TSRTLSYYK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TSSMRGVYY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
TSSMRGVYY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
TSSMRGVYY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
TSSMRGVYY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
TSSMRGVYY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TSSMRGVYY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
TSTGNYNYK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
TSTGNYNYK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
TSTGNYNYK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
TSTGNYNYK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
TSTGNYNYKY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
TSTGNYNYKY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),18
TSTGNYNYKY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),38
TSTGNYNYKY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
TSTGNYNYKY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TSTGNYNYKY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
TTGIGYQPY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
TTGIGYQPY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),31
TTGIGYQPY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
TTGIGYQPY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TTGIGYQPY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
TTGIGYQPY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
TTGIGYQPYR,HLA-A03:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
TTGIGYQPYR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
TTGIGYQPYR,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
TTGIGYQPYR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
TTLPKGFYA,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,4
TTLPVNVAF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
TTLPVNVAF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
TTLPVNVAF,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,6
TTLPVNVAF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1
TTLPVNVAF,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.2
TTLPVNVAF,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.4
TTLPVNVAF,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1
TTLPVNVAF,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2
TTLPVNVAF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
TTLPVNVAF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5
TTLPVNVAF,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
TTLPVNVAF,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.7
TTLPVNVAF,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.7
TTLPVNVAF,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
TTLPVNVAF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
TTLPVNVAF,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.07
TTLPVNVAF,HLA-B58:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.07
TTTGIGYQPY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
TTTGIGYQPY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
TTTGIGYQPY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),35
TTTGIGYQPY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
TTTGIGYQPY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
TTTGIGYQPY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
TTTSTALGK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
TTTSTALGK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
TTTSTALGK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
TTTSTALGK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
TVATSRTLSY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
TVATSRTLSY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),27
TVATSRTLSY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
TVATSRTLSY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
TVATSRTLSY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
TVATSRTLSY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
TVLSFCAFA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
TVLSFCAFA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7.5
TVLSFCAFA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
TVVQRCASNK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
TVVQRCASNK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
TVVQRCASNK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
TVVQRCASNK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
TVYVYSRVK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
TVYVYSRVK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
TVYVYSRVK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
TVYVYSRVK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
TWLTYHGAI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),40
TWLTYHGAI,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
TWLTYHGAI,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
TWLTYHGAI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
TWLTYHGAI,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),16
TWLTYHGAI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
TYVPSQERNF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),47
TYVPSQERNF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.02
TYVPSQERNF,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
TYVPSQERNF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
TYVPSQERNF,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
TYVPSQERNF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
VFAQVKQMY,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
VFAQVKQMY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
VFAQVKQMY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
VFAQVKQMY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
VFAQVKQMY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
VFAQVKQMY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
VFAQVKQMYK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
VFAQVKQMYK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
VFAQVKQMYK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
VFAQVKQMYK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
VFGSTMNNK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
VFGSTMNNK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
VFGSTMNNK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
VFGSTMNNK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
VFLILCFTI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),60
VFLILCFTI,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
VFLILCFTI,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
VFLILCFTI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),65
VFLILCFTI,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
VFLILCFTI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
VFLILCFTIK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
VFLILCFTIK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
VFLILCFTIK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
VFLILCFTIK,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
VFNGTSWFI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
VFNGTSWFI,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
VFNGTSWFI,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
VFNGTSWFI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),47
VFNGTSWFI,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
VFNGTSWFI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
VFQSATKII,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),47
VFQSATKII,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
VFQSATKII,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
VFQSATKII,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),65
VFQSATKII,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),23
VFQSATKII,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
VIADYNYKL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.25
VIADYNYKL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
VIADYNYKL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
VIADYNYKL,HLA-A02:01,T Cell,Negative,51 chromium,cytotoxicity,0.25
VIADYNYKL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.25
VIADYNYKL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
VIADYNYKL,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
VIADYNYKL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
VIADYNYKL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
VLAALVCYI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
VLAALVCYI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.17
VLAALVCYI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
VLAALVCYIV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.5
VLAALVCYIV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
VLAALVCYIV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6.5
VLAWLYAAV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
VLAWLYAAV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.25
VLAWLYAAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
VLAWLYAAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
VLAWLYAAV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
VLAWLYAAV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
VLLFLAFVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
VLLFLAFVV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
VLLFLAFVV,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.3
VLLFLAFVV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
VLLFLAFVV,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5
VLLFLAFVV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
VLLFLAFVV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7.5
VLNDILSRL,HLA-A02:01,T Cell,Positive,ELISPOT,IFNg release,0.06
VLNDILSRL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,0.06
VLNDILSRL,HLA-A02:01,T Cell,Positive,51 chromium,cytotoxicity,0.06
VLNDILSRL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.06
VLNDILSRL,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.06
VLQAVGACV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
VLQAVGACV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
VLQAVGACV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
VLQLPQGTTL,HLA-A02:01,MHC Binding,Positive-Low,cellular MHC/direct/fluorescence,qualitative binding,1.9
VLQLPQGTTL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.9
VLSFCAFAV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
VLSFCAFAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
VLSFCAFAV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
VLWAHGFEL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
VLWAHGFEL,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3
VLWAHGFEL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.08
VLWAHGFEL,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.08
VLWAHGFEL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
VLWAHGFEL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.08
VLWAHGFEL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.08
VLWAHGFEL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
VLWAHGFEL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
VLWAHGFEL,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.6
VLWAHGFEL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.6
VLWAHGFEL,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
VLWAHGFEL,HLA-A24:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,1.2
VLWAHGFEL,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
VLWAHGFEL,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),7.5
VLWAHGFEL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
VLWAHGFEL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
VLWAHGFEL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
VLWAHGFEL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4
VLWAHGFEL,HLA-B08:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.3
VLWAHGFEL,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
VLWAHGFEL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
VLWAHGFEL,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
VLWAHGFEL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8.5
VLWAHGFEL,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),9.5
VLWAHGFEL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
VLYENQKQI,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.25
VLYENQKQI,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.25
VLYQDVNCT,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,1.7
VMCGGSLYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
VMCGGSLYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
VMCGGSLYV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
VMFNGVTFST,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
VMFNGVTFST,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8.5
VMFNGVTFST,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),20
VMVTILLCCM,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
VMVTILLCCM,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),25
VMVTILLCCM,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),20
VMVTILLCCM,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),20
VMVTILLCCM,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),34
VMVTILLCCM,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),34
VMYASALVLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.3
VMYASALVLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
VMYASALVLL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),8
VPGLPGTVL,HLA-B07:02,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.01
VPMEKLKAL,HLA-B07:02,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.06
VPMEKLKAL,HLA-B07:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
VPMEKLKAL,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
VPMEKLKAL,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.6
VPMEKLKAL,HLA-B51:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
VPMEKLKAL,HLA-B53:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.7
VPMEKLKAL,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
VPSGDVVRF,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
VPSGDVVRF,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
VPSGDVVRF,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
VPSGDVVRF,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),11
VPSGDVVRF,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.5
VPSGDVVRF,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
VPSGDVVRF,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
VPSGDVVRF,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.6
VPSGDVVRF,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.6
VPSGDVVRF,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
VPSGDVVRF,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.1
VPSGDVVRF,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
VPSGDVVRF,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
VPSGDVVRF,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.1
VQIDRLITGR,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.8
VQIDRLITGR,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2
VQIDRLITGR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
VQIDRLITGR,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
VQQESSFVM,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
VQQESSFVM,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
VQQESSFVM,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),9
VQQESSFVM,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
VQQESSFVM,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
VQQESSFVM,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
VQQESSFVM,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
VQQESSFVM,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
VQQESSFVM,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
VQQESSFVM,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,29
VQQESSFVM,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.9
VQQESSFVM,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.9
VQQESSFVM,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.9
VQQESSFVM,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
VQQESSFVM,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
VQQESSFVM,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),10
VQQESSFVM,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
VQTVRTQVY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
VQTVRTQVY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
VQTVRTQVY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,43
VQTVRTQVY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
VQTVRTQVY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),12
VQTVRTQVY,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),25
VQTVRTQVY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9
VQTVRTQVY,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
VQTVRTQVY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
VQTVRTQVY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),17
VQTVRTQVY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,17
VQTVRTQVY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
VQTVRTQVY,HLA-B15:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.03
VQTVRTQVY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.03
VQTVRTQVY,HLA-B15:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.03
VQTVRTQVY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,12
VQTVRTQVY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
VQTVRTQVY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),30
VQTVRTQVY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
VRDPKTSEI,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
VRDPKTSEI,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7
VRDPKTSEI,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,28
VRDPKTSEI,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),37
VRDPKTSEI,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
VRDPKTSEI,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,34
VRDPKTSEI,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),8
VRDPKTSEI,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
VRDPKTSEI,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
VRDPKTSEI,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.6
VRDPKTSEI,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
VRDPKTSEI,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,7.5
VRFPNITNL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
VRFPNITNL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.5
VRFPNITNL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
VRFPNITNL,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6
VRFPNITNL,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4.5
VRFPNITNL,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
VRFPNITNL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3.5
VRFPNITNL,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
VRFPNITNL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
VRFPNITNL,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.03
VRFPNITNL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.8
VRFPNITNL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5
VRFPNITNL,HLA-C14:02,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),2.5
VSLLRSTSQK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.9
VSLLRSTSQK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
VSLLRSTSQK,HLA-A31:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
VSLLRSTSQK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
VSLVKPTVY,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
VSLVKPTVY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
VSLVKPTVY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
VSLVKPTVY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
VSLVKPTVY,HLA-A29:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
VSLVKPTVY,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
VTFQGKFKK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.4
VTFQGKFKK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/direct/radioactivity,half life,0.01
VTLADAGFMK,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
VTLADAGFMK,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
VTLADAGFMK,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
VTLADAGFMK,HLA-A68:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
VTLAILTALR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
VTLAILTALR,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
VTLAILTALR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
VTLAILTALR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
VTPSGTWLT,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,35
VTPSGTWLTY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.1
VTPSGTWLTY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
VTPSGTWLTY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
VTPSGTWLTY,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
VTPSGTWLTY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
VTPSGTWLTY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.3
VTPSGTWLTY,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,38
VTPSGTWLTYH,HLA-B40:01,MHC Binding,Negative,purified MHC,qualitative binding,60
VTYVPSQER,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.2
VTYVPSQER,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
VTYVPSQER,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
VTYVPSQER,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
VVDKYFDCY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
VVDKYFDCY,HLA-A01:01,MHC Binding,Positive-Intermediate,purified MHC/direct/radioactivity,half life,0.04
VVDKYFDCY,HLA-A01:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.04
VVDKYFDCY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
VVDKYFDCY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6
VVDKYFDCY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
VVDKYFDCY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,21
VVDKYFDCY,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),21
VVDKYFDCY,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
VVDKYFDCY,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
VVDKYFDCY,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
VVDKYFDCY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,46
VVDKYFDCY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
VVDKYFDCY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,44
VVDKYFDCY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
VVFLHVTYV,HLA-A02:01,MHC Binding,Positive,cellular MHC/direct/fluorescence,qualitative binding,0.8
VVFLHVTYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.8
VVFLHVTYV,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.8
VVFLHVTYV,HLA-A02:01,T Cell,Positive,ELISA,IFNg release,0.8
VVFLHVTYV,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.8
VVFLHVTYV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
VVFLHVTYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
VVFLHVTYV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
VVFLHVTYV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.15
VVFLHVTYV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
VVHGYFTEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.1
VVHGYFTEV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
VVHGYFTEV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
VVHGYFTEV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
VVHGYFTEV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
VVHGYFTEV,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
VVQRCASNK,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
VVQRCASNK,HLA-A11:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
VVQRCASNK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
VVQRCASNK,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
VVYRGTTTY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
VVYRGTTTY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,0.2
VVYRGTTTY,HLA-A03:01,MHC Binding,Positive-High,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.2
VVYRGTTTY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.3
VVYRGTTTY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
VVYRGTTTY,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
VVYRGTTTY,HLA-B35:01,MHC Binding,Positive-Low,purified MHC/direct/radioactivity,half life,1.7
VVYRGTTTY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
VVYRGTTTY,HLA-B58:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
VWLGFIAGL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
VWLGFIAGL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
VWLGFIAGL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
VWLGFIAGL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
VWLGFIAGL,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5
VWLGFIAGL,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
VYALCTLLHL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
VYALCTLLHL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
VYALCTLLHL,HLA-A24:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
VYALCTLLHL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),26
VYALCTLLHL,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
VYALCTLLHL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),42
VYAWERKKI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),45
VYAWERKKI,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
VYAWERKKI,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.2
VYAWERKKI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),24
VYAWERKKI,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
VYAWERKKI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
VYDPLQPEL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1
VYDPLQPEL,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
VYDPLQPEL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.3
VYDPLQPEL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,22
VYDPLQPEL,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
VYDPLQPEL,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
VYDPLQPEL,HLA-A24:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.03
VYDPLQPEL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),35
VYDPLQPEL,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
VYDPLQPEL,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
VYDPLQPEL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.8
VYDPLQPEL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
VYDPLQPEL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.3
VYDPLQPEL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,4
VYHITVSQI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),33
VYHITVSQI,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
VYHITVSQI,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
VYHITVSQI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),25
VYHITVSQI,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
VYHITVSQI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
WFITQRNFF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
WFITQRNFF,HLA-A23:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
WFITQRNFF,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
WFITQRNFF,HLA-A26:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
WFITQRNFF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
WFITQRNFF,HLA-A30:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
WIMLLQFAY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
WIMLLQFAY,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
WIMLLQFAY,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
WIMLLQFAY,HLA-A68:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
WLLWPVTLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
WLLWPVTLA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
WLLWPVTLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
WLLWPVTLA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
WLLWPVTLA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),19
WLLWPVTLA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),19
WLMWFIISI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.09
WLMWFIISI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.09
WLMWFIISI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.04
WLMWFIISI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
WLMWFIISI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
WLMWFIISI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.3
WLMWFIISIV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
WLMWFIISIV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
WLMWFIISIV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6.5
WLPTGTLLV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
WLPTGTLLV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
WLPTGTLLV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
WLSYFVASFR,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
WLSYFVASFR,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8
WLSYFVASFR,HLA-A31:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
WLSYFVASFR,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
WLTYHGAIKL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.6
WLTYHGAIKL,HLA-A02:01,MHC Binding,Positive-High,cellular MHC/direct/fluorescence,qualitative binding,1.6
WLVIGVAFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
WLVIGVAFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
WLVIGVAFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
WLVIGVAFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
WLVIGVAFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1
WLVIGVAFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1
WMLLTFLTSL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
WMLLTFLTSL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6.5
WMLLTFLTSL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),39
WPVTLACFVL,HLA-B07:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
WPVTLACFVL,HLA-B35:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.1
WPVTLACFVL,HLA-B51:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
WPVTLACFVL,HLA-B53:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9.5
WPVTLACFVL,HLA-B54:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
WPWYVWLGFI,HLA-B07:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
WPWYVWLGFI,HLA-B35:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
WPWYVWLGFI,HLA-B51:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
WPWYVWLGFI,HLA-B53:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
WPWYVWLGFI,HLA-B54:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
WVFGSTMNNK,HLA-A03:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
WVFGSTMNNK,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
WVFGSTMNNK,HLA-A31:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6.5
WVFGSTMNNK,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.125
WVLAYMLFT,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),11
WVLAYMLFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),20
WVLAYMLFT,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),17
YAEISFMLW,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.3
YAEISFMLW,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
YAEISFMLW,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
YAEISFMLW,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
YAEISFMLW,HLA-A24:02,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,3.5
YAEISFMLW,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,24
YAEISFMLW,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
YAEISFMLW,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,25
YAEISFMLW,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,13
YAEISFMLW,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,20
YAEISFMLW,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,43
YAEISFMLW,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,23
YAEISFMLW,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
YAEISFMLW,HLA-B58:01,MHC Binding,Positive-High,purified MHC/competitive/fluorescence,dissociation constant KD,3
YALCTLLHL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
YALCTLLHL,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
YALCTLLHL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
YASALVLLI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
YASALVLLI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
YASALVLLI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
YEGNSPFHPL,HLA-B18:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
YEGNSPFHPL,HLA-B40:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
YEGNSPFHPL,HLA-B40:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
YEGNSPFHPL,HLA-B44:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
YEGNSPFHPL,HLA-B44:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
YEGNSPFHPL,HLA-B45:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),8.5
YEQYIKWPWY,HLA-B18:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
YEQYIKWPWY,HLA-B40:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7.5
YEQYIKWPWY,HLA-B40:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
YEQYIKWPWY,HLA-B44:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
YEQYIKWPWY,HLA-B44:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
YEQYIKWPWY,HLA-B45:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
YFPREGVFVF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
YFPREGVFVF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
YFPREGVFVF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
YFPREGVFVF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
YFPREGVFVF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
YFPREGVFVF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),32
YFTEVYYQL,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
YFTEVYYQL,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.04
YFTEVYYQL,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
YFTEVYYQL,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),5.5
YFTEVYYQL,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
YFTEVYYQL,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
YFVASFRLF,HLA-A01:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),9
YFVASFRLF,HLA-A23:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.17
YFVASFRLF,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.08
YFVASFRLF,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
YFVASFRLF,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
YFVASFRLF,HLA-A30:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
YFVCWHTHNY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),43
YFVCWHTHNY,HLA-A11:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),39
YFVCWHTHNY,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),29
YFVCWHTHNY,HLA-A68:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),34
YIFFASFYY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.08
YIFFASFYY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,6.5
YIFFASFYY,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),6.5
YIFFASFYY,HLA-A03:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.8
YIFFASFYY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,0.8
YIFFASFYY,HLA-A03:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.8
YIFFASFYY,HLA-A11:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.5
YIFFASFYY,HLA-A11:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
YIFFASFYY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,9.5
YIFFASFYY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),1.6
YIFFASFYY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,10
YIFFASFYY,HLA-A31:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),10
YIFFASFYY,HLA-A68:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
YIFFASFYY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
YIFFASFYY,HLA-B08:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,44
YIFFASFYY,HLA-B15:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.4
YIFFASFYY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,0.4
YIFFASFYY,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/radioactivity,half life,0.4
YIFFASFYY,HLA-B27:05,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3.5
YIFFASFYY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
YIFFASFYY,HLA-B46:01,MHC Binding,Negative,purified MHC/competitive/fluorescence,dissociation constant KD,1.3
YIFFASFYY,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
YIFFASFYY,HLA-B58:01,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),3
YIFFASFYYI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
YIFFASFYYI,HLA-A02:03,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6.5
YIFFASFYYI,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.2
YIIKLVFLWL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3.5
YIIKLVFLWL,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3.5
YIIKLVFLWL,HLA-A02:03,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.6
YIIKLVFLWL,HLA-A02:03,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1.6
YIIKLVFLWL,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),1.4
YIIKLVFLWL,HLA-A68:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.4
YISDAFSLDV,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,1.8
YIWKSYVHI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.7
YIWKSYVHI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
YIWKSYVHI,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
YLCFLAFLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
YLCFLAFLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
YLCFLAFLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4.5
YLCFLAFLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4.5
YLCFLAFLL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),2.5
YLCFLAFLL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
YLDAYNMMI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
YLDAYNMMI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),4
YLDAYNMMI,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),18
YLGTGPEASL,HLA-A02:01,MHC Binding,Positive-High,cellular MHC/direct/fluorescence,qualitative binding,0.4
YLGTGPEASL,HLA-A02:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.4
YLGTGPEASL,HLA-A02:01,T Cell,Negative,ELISPOT,IFNg release,0.4
YLLGLSAIM,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.7
YLLGLSAIM,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
YLLGLSAIM,HLA-A68:02,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),18
YLMCLSPLM,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
YLMCLSPLM,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),6
YLMCLSPLM,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),22
YLMCLSPLMA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.7
YLMCLSPLMA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),1.5
YLMCLSPLMA,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),36
YLNTLTLAV,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.12
YLNTLTLAV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
YLNTLTLAV,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),5.5
YLSSVLLAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.05
YLSSVLLAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.05
YLSSVLLAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.06
YLSSVLLAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.06
YLSSVLLAL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
YLSSVLLAL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
YLVQQESSFV,HLA-A02:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.6
YLVQQESSFV,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.4
YLVQQESSFV,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
YLYALIYFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.01
YLYALIYFL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.01
YLYALIYFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.07
YLYALIYFL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.07
YLYALIYFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.4
YLYALIYFL,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
YLYLTFYFT,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
YLYLTFYFT,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),6
YLYLTFYFT,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),15
YMLFTKFFYL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.9
YMLFTKFFYL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),14
YMLFTKFFYL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),12
YMPYVFTLL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
YMPYVFTLL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
YMPYVFTLL,HLA-A23:01,MHC Binding,Negative,cellular MHC/competitive/fluorescence,half maximal inhibitory concentration (IC50),0.4
YMPYVFTLL,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.6
YQCGHYTHI,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),7
YQCGHYTHI,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
YQCGHYTHI,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),2.5
YQCGHYTHI,HLA-A68:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),11
YQKVGMQKY,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,3
YQKVGMQKY,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
YQKVGMQKY,HLA-A24:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,18
YQKVGMQKY,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,16
YQKVGMQKY,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,31
YQKVGMQKY,HLA-B15:01,MHC Binding,Positive,purified MHC/direct/fluorescence,qualitative binding,0.01
YQKVGMQKY,HLA-B27:05,MHC Binding,Positive-Low,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),5.5
YQKVGMQKY,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,30
YRYLRHGKL,HLA-A01:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,11
YRYLRHGKL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,14
YRYLRHGKL,HLA-A03:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,32
YRYLRHGKL,HLA-A11:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,70
YRYLRHGKL,HLA-A26:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,15
YRYLRHGKL,HLA-A31:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,70
YRYLRHGKL,HLA-B07:02,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,5.5
YRYLRHGKL,HLA-B08:01,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),4
YRYLRHGKL,HLA-B15:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,19
YRYLRHGKL,HLA-B27:05,MHC Binding,Positive-Intermediate,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),0.6
YRYLRHGKL,HLA-B40:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,8
YRYLRHGKL,HLA-B58:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,33
YSNRNRFLY,HLA-A01:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.03
YSNRNRFLY,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),15
YSNRNRFLY,HLA-A24:02,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),13
YSNRNRFLY,HLA-A26:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),7
YSNRNRFLY,HLA-A29:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.25
YSNRNRFLY,HLA-A30:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
YTMADLVYA,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
YTMADLVYA,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.8
YTMADLVYA,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.9
YVFCTVNAL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),1.2
YVFCTVNAL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.5
YVFCTVNAL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
YVFTLLFQL,HLA-A02:01,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.4
YVFTLLFQL,HLA-A02:03,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.3
YVFTLLFQL,HLA-A68:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),0.03
YVVVHGYFT,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
YVVVHGYFT,HLA-A02:01,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),11
YVVVHGYFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),30
YVVVHGYFT,HLA-A02:03,MHC Binding,Positive-Low,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
YVVVHGYFT,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),3
YVVVHGYFT,HLA-A68:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,half maximal inhibitory concentration (IC50),3
YVWLGFIAGL,HLA-A02:01,MHC Binding,Negative,purified MHC/direct/fluorescence,qualitative binding,2.5
YWPLNDYGF,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),12
YWPLNDYGF,HLA-A23:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.5
YWPLNDYGF,HLA-A24:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.15
YWPLNDYGF,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),4
YWPLNDYGF,HLA-A29:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.9
YWPLNDYGF,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),36
YYQLESTQI,HLA-A01:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14
YYQLESTQI,HLA-A23:01,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.6
YYQLESTQI,HLA-A24:02,MHC Binding,Positive-High,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),0.12
YYQLESTQI,HLA-A26:01,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),30
YYQLESTQI,HLA-A29:02,MHC Binding,Positive-Intermediate,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),11
YYQLESTQI,HLA-A30:02,MHC Binding,Negative,purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),14